data_2n5c_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n5c _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.104 1 N-CA-C 97.051 -6.42 . . . . 60.43 97.051 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -134.43 110.66 9.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 121.328 2.564 . . . . 74.230000000000004 111.109 165.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.56 -174.81 43.89 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.068 -0.813 . . . . 74.129999999999995 111.068 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 80.76 9.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.331 1.234 . . . . 74.049999999999997 114.331 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.97 171.04 7.97 Favored Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 105.655 -1.98 . . . . 74.420000000000002 105.655 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.61 -162.26 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.765 0 CA-C-N 119.759 0.95 . . . . 61.520000000000003 112.925 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -48.82 148.65 2.1 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 120.144 3.387 . . . . 63.450000000000003 120.144 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -155.11 167.59 29.85 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 111.785 -2.461 . . . . 71.420000000000002 108.418 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -64.76 -22.99 67.1 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.643 -1.286 . . . . 72.409999999999997 114.291 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -117.04 30.58 7.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.811 1.767 . . . . 72.409999999999997 109.071 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.59 -80.94 0.34 Allowed Glycine 0 C--O 1.225 -0.448 0 CA-C-O 118.394 -1.225 . . . . 73.209999999999994 116.083 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.62 130.75 47.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.087 1.443 . . . . 75.439999999999998 110.189 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.04 149.59 44.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 119.399 3.111 . . . . 74.319999999999993 119.399 -160.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -74.74 174.56 8.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.949 -1.023 . . . . 72.25 111.638 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.3 p90 . . . . . 0 C--O 1.253 1.283 1 N-CA-C 99.922 -4.103 . . . . 74.120000000000005 99.922 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 N-CA-C 108.777 -1.729 . . . . 74.310000000000002 108.777 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -161.74 154.02 19.71 Favored 'General case' 0 C--N 1.324 -0.512 1 N-CA-C 100.114 -4.032 . . . . 75.420000000000002 100.114 150.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.89 -158.33 27.65 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 120.905 1.684 . . . . 55.520000000000003 116.493 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 p -117.36 12.14 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.066 1.876 . . . . 72.120000000000005 116.066 -169.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.25 165.56 12.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 106.864 -1.532 . . . . 75.010000000000005 106.864 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.03 -176.56 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 119.384 0.816 . . . . 73.400000000000006 113.017 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.7 mt -51.96 134.15 32.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 118.275 2.694 . . . . 73.120000000000005 118.275 -147.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -99.63 174.47 6.22 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 111.985 -2.371 . . . . 63.0 105.696 171.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 t -65.8 -24.02 66.83 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.985 -1.697 . . . . 71.030000000000001 110.868 164.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -123.13 81.81 1.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.893 1.33 . . . . 73.310000000000002 109.622 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.17 -106.94 2.29 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.516 -0.85 . . . . 75.420000000000002 115.117 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.53 154.02 35.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.566 -0.901 . . . . 64.129999999999995 108.566 -173.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -96.07 152.34 18.63 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 117.475 2.398 . . . . 73.420000000000002 117.475 -166.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -69.72 179.3 2.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.497 -1.229 . . . . 75.109999999999999 113.349 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.4 p90 . . . . . 0 C--O 1.255 1.343 1 N-CA-C 98.94 -4.467 . . . . 73.209999999999994 98.94 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.132 1 N-CA-C 101.545 -4.622 . . . . 53.450000000000003 101.545 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.48 106.75 5.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.93 1.865 . . . . 75.329999999999998 111.367 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.89 172.33 43.92 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 107.497 -2.241 . . . . 63.520000000000003 107.497 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.95 113.25 20.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.512 1.156 . . . . 74.129999999999995 110.525 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -175.36 -179.64 0.39 Allowed Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 101.715 -3.439 . . . . 74.319999999999993 101.715 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.62 -170.69 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 117.03 -1.513 . . . . 73.150000000000006 112.601 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.46 145.19 11.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 116.292 1.96 . . . . 75.030000000000001 116.292 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.304 17.6 t0 -99.93 -163.17 1.01 Allowed 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 127.837 2.455 . . . . 73.430000000000007 108.22 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -67.02 -31.19 71.56 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.656 -2.528 . . . . 71.209999999999994 114.796 159.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -147.56 128.45 14.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.943 -2.614 . . . . 74.040000000000006 103.943 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.24 -150.57 37.26 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 119.627 -1.273 . . . . 41.0 112.732 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.1 mt -114.34 143.81 44.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.047 -1.094 . . . . 74.420000000000002 108.047 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -64.49 136.9 57.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.261 1.578 . . . . 73.329999999999998 115.261 -163.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -62.05 168.54 3.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.377 -1.283 . . . . 75.400000000000006 112.683 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 17.3 t80 . . . . . 0 C--O 1.253 1.269 1 N-CA-C 97.736 -4.913 . . . . 73.120000000000005 97.736 172.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.352 1 N-CA-C 97.131 -6.388 . . . . 75.329999999999998 97.131 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -131.05 105.76 7.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.625 2.213 . . . . 74.420000000000002 110.955 165.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.02 -176.2 45.83 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 108.658 -1.777 . . . . 75.439999999999998 108.658 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.42 105.06 17.55 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 115.295 1.591 . . . . 54.43 115.295 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.432 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.3 OUTLIER -177.54 175.4 0.56 Allowed Pre-proline 0 N--CA 1.478 0.968 0 N-CA-C 101.116 -3.661 . . . . 75.329999999999998 101.116 166.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.69 -164.16 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 CA-C-N 120.753 1.305 . . . . 74.409999999999997 114.902 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.4 mt -47.45 145.65 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 120.217 3.414 . . . . 72.219999999999999 120.217 -166.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -155.56 168.95 25.46 Favored 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 127.745 2.418 . . . . 74.120000000000005 107.958 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -58.56 -37.3 75.44 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.94 1.089 . . . . 71.420000000000002 113.94 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -106.12 30.3 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.265 1.507 . . . . 72.140000000000001 109.846 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.27 -77.84 0.23 Allowed Glycine 0 C--O 1.226 -0.386 0 CA-C-O 118.389 -1.228 . . . . 73.329999999999998 115.141 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.35 137.63 48.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.286 1.543 . . . . 73.219999999999999 112.361 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.4 130.86 43.69 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.56 2.059 . . . . 73.040000000000006 116.56 -166.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -79.51 170.24 16.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 73.299999999999997 111.65 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.432 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 46.8 t80 . . . . . 0 C--O 1.254 1.336 1 N-CA-C 99.14 -4.392 . . . . 73.340000000000003 99.14 165.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 0.065 1 N-CA-C 98.529 -5.828 . . . . 72.420000000000002 98.529 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -132.47 93.1 3.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.131 2.465 . . . . 75.219999999999999 112.526 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.74 -176.45 45.76 Favored Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.699 -1.76 . . . . 73.209999999999994 108.699 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.91 104.64 16.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 115.913 1.82 . . . . 73.099999999999994 115.913 -175.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -177.0 174.89 0.63 Allowed Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 100.828 -3.768 . . . . 74.430000000000007 100.828 166.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.82 -164.61 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 120.808 1.324 . . . . 73.310000000000002 115.461 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -47.21 144.66 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 119.669 3.211 . . . . 73.25 119.669 -167.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -156.54 166.11 34.34 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 127.484 2.314 . . . . 70.439999999999998 108.096 -169.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -28.26 67.85 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 116.398 1.999 . . . . 73.349999999999994 116.398 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -114.03 27.67 9.34 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 123.309 1.528 . . . . 62.439999999999998 109.202 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.49 -79.52 0.26 Allowed Glycine 0 C--O 1.226 -0.358 0 CA-C-O 118.499 -1.167 . . . . 73.5 115.193 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.51 136.4 47.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.119 1.459 . . . . 73.540000000000006 112.827 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.04 133.15 46.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.565 2.061 . . . . 62.310000000000002 116.565 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -88.18 170.59 10.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 70.219999999999999 111.071 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 C--O 1.256 1.426 1 N-CA-C 98.453 -4.647 . . . . 73.329999999999998 98.453 167.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.135 0 N-CA-C 103.719 -3.752 . . . . 60.109999999999999 103.719 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -138.06 110.39 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.002 1.401 . . . . 70.530000000000001 110.409 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.64 167.95 37.15 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 107.398 -2.281 . . . . 41.520000000000003 107.398 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.21 109.73 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.895 1.347 . . . . 74.319999999999993 109.954 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -173.81 178.27 0.61 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 102.439 -3.171 . . . . 74.340000000000003 102.439 -178.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.2 -173.48 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 116.718 -1.722 . . . . 74.200000000000003 112.379 167.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.2 mt -50.72 139.28 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 115.849 1.796 . . . . 75.329999999999998 115.849 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.268 7.7 t0 -85.21 -164.77 1.05 Allowed 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 112.115 -2.311 . . . . 64.310000000000002 107.502 168.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -65.79 -33.33 75.61 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.801 -2.437 . . . . 71.239999999999995 113.413 160.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -153.68 129.14 9.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 103.899 -2.63 . . . . 75.409999999999997 103.899 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.29 -156.92 26.41 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.757 -0.735 . . . . 72.040000000000006 111.384 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.0 mt -118.63 142.08 47.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.095 -1.817 . . . . 74.129999999999995 106.095 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -61.94 135.07 57.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.966 1.469 . . . . 74.310000000000002 114.966 -162.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -62.99 172.23 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.241 -1.345 . . . . 73.519999999999996 113.607 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.417 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 72.3 t80 . . . . . 0 C--O 1.254 1.324 1 N-CA-C 98.521 -4.622 . . . . 71.530000000000001 98.521 169.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.152 1 N-CA-C 101.165 -4.774 . . . . 73.329999999999998 101.165 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -106.78 150.05 26.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 101.284 -3.599 . . . . 75.209999999999994 101.284 161.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.39 -161.19 27.06 Favored Glycine 0 C--O 1.222 -0.609 0 CA-C-N 119.55 1.068 . . . . 74.109999999999999 112.242 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 p -108.88 -6.98 15.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.679 1.362 . . . . 64.420000000000002 114.679 -170.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -133.5 163.07 53.75 Favored Pre-proline 0 C--O 1.218 -0.572 0 N-CA-C 105.805 -1.924 . . . . 73.319999999999993 105.805 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.66 172.13 15.84 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 115.83 -2.314 . . . . 73.209999999999994 113.892 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . 0.411 2.5 pp 68.45 111.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 121.224 3.787 . . . . 73.319999999999993 121.224 169.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -174.8 168.78 3.59 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 100.923 -3.732 . . . . 72.439999999999998 100.923 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -68.82 -25.76 64.83 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 121.274 1.852 . . . . 75.349999999999994 111.639 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -99.45 15.23 27.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 123.006 1.384 . . . . 71.549999999999997 109.432 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.39 -36.74 4.01 Favored Glycine 0 N--CA 1.454 -0.134 0 N-CA-C 119.688 2.635 . . . . 73.319999999999993 119.688 170.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.06 128.28 43.24 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 116.943 2.201 . . . . 73.430000000000007 116.943 -173.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -72.0 132.44 44.28 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.048 -1.033 . . . . 74.239999999999995 111.8 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -99.56 133.62 43.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 63.210000000000001 111.949 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.1 t80 . . . . . 0 C--O 1.263 1.775 1 N-CA-C 95.979 -5.563 . . . . 75.540000000000006 95.979 161.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.31 0 N-CA-C 106.38 -2.688 . . . . 61.520000000000003 106.38 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -127.47 137.2 52.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 102.922 -2.992 . . . . 74.400000000000006 102.922 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.46 -169.4 41.89 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 107.735 -2.146 . . . . 65.430000000000007 107.735 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.1 p -97.41 -7.96 30.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 115.266 1.58 . . . . 72.310000000000002 115.266 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -102.69 157.03 34.53 Favored Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 121.745 -0.597 . . . . 73.420000000000002 111.129 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.94 176.49 7.59 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 116.46 -1.893 . . . . 72.099999999999994 112.138 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pp 40.68 74.04 0.11 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 118.74 2.867 . . . . 74.230000000000004 118.74 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -70.16 -174.16 0.77 Allowed 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.528 -1.358 . . . . 75.25 108.411 151.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -59.98 -36.06 76.35 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.499 -2.001 . . . . 75.040000000000006 113.184 162.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.53 132.79 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 102.554 -3.128 . . . . 74.219999999999999 102.554 167.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.55 -153.53 21.71 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 119.076 0.853 . . . . 63.399999999999999 113.556 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.03 136.84 47.04 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.326 0.65 . . . . 74.549999999999997 110.326 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.9 123.95 23.81 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.113 -0.992 . . . . 74.230000000000004 112.991 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -62.69 158.62 18.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.453 -1.703 . . . . 75.200000000000003 112.99 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.6 t80 . . . . . 0 C--O 1.256 1.447 1 N-CA-C 99.548 -4.241 . . . . 74.409999999999997 99.548 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.372 0 N-CA-C 104.251 -3.54 . . . . 73.049999999999997 104.251 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -138.59 125.01 20.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.02 -2.215 . . . . 73.129999999999995 105.02 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.86 -162.52 30.25 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.913 -0.875 . . . . 63.009999999999998 110.913 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.9 p -100.72 -2.06 33.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.867 2.173 . . . . 72.209999999999994 116.867 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 163.04 20.3 Favored Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 121.335 -0.853 . . . . 74.400000000000006 109.599 -174.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.0 178.13 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 119.08 0.707 . . . . 74.530000000000001 112.598 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.6 mt -50.91 135.26 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 118.551 2.797 . . . . 73.040000000000006 118.551 -149.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.305 5.9 t0 -78.88 -164.11 0.56 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 110.88 -2.873 . . . . 64.019999999999996 108.467 171.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.7 p -65.78 -33.59 76.21 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 118.404 -2.685 . . . . 74.129999999999995 113.692 160.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -147.28 128.87 15.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.558 -2.386 . . . . 75.329999999999998 104.558 173.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.65 -159.31 44.14 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 119.889 1.222 . . . . 72.230000000000004 113.86 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.4 147.0 23.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.119 0.568 . . . . 74.239999999999995 109.549 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -72.02 128.78 36.79 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 115.266 1.58 . . . . 75.439999999999998 115.266 -169.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -62.48 158.64 17.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.0 -1.909 . . . . 75.200000000000003 114.499 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--O 1.253 1.25 1 N-CA-C 99.353 -4.314 . . . . 73.109999999999999 99.353 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.606 0 N-CA-C 105.143 -3.183 . . . . 71.120000000000005 105.143 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -147.08 118.71 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.742 -1.577 . . . . 75.540000000000006 106.742 150.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.19 -158.65 28.43 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.103 1.201 . . . . 45.219999999999999 116.103 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.4 p -91.38 2.96 56.03 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 119.494 3.146 . . . . 74.310000000000002 119.494 -169.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HZ2' ' HB2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -104.52 170.16 6.37 Favored Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 121.073 -1.017 . . . . 74.439999999999998 108.299 -177.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -64.31 -172.23 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 119.76 0.95 . . . . 61.310000000000002 113.895 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 mp -48.31 134.89 14.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 117.715 2.487 . . . . 75.109999999999999 117.715 -165.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.324 23.1 t0 -100.73 -165.75 1.24 Allowed 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 128.989 2.916 . . . . 74.420000000000002 109.142 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -31.01 70.32 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 119.204 -2.185 . . . . 61.399999999999999 115.364 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -147.91 127.11 12.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.796 -1.928 . . . . 72.340000000000003 105.796 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 -144.36 43.24 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 119.056 -1.545 . . . . 75.129999999999995 113.864 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.81 146.89 26.71 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.636 0.774 . . . . 73.430000000000007 110.433 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -73.62 134.85 43.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 116.369 1.988 . . . . 75.409999999999997 116.369 -168.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -60.49 158.92 11.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.066 -1.879 . . . . 75.109999999999999 113.681 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--O 1.252 1.203 1 N-CA-C 97.751 -4.907 . . . . 75.209999999999994 97.751 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.699 0 N-CA-C 106.533 -2.627 . . . . 73.450000000000003 106.533 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -148.71 137.07 21.14 Favored 'General case' 0 C--N 1.322 -0.603 1 N-CA-C 100.131 -4.026 . . . . 74.019999999999996 100.131 140.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.28 -158.49 31.14 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 120.529 1.513 . . . . 73.230000000000004 116.624 -173.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.3 p -104.7 -3.83 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 118.269 2.692 . . . . 75.099999999999994 118.269 -172.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HZ2' ' HB2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -96.47 170.81 6.94 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 105.837 -1.912 . . . . 74.310000000000002 105.837 -177.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -64.93 -167.92 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 N-CA-C 115.154 1.175 . . . . 71.340000000000003 115.154 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -47.24 133.18 12.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 116.75 2.13 . . . . 72.310000000000002 116.75 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.288 27.0 t0 -107.59 -169.34 1.51 Allowed 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 111.724 -2.489 . . . . 74.420000000000002 108.563 -173.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -62.17 -31.77 72.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 119.366 -2.084 . . . . 75.219999999999999 113.929 159.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -141.71 120.6 12.75 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 108.252 -1.018 . . . . 73.120000000000005 108.252 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.81 -133.54 32.01 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 119.126 -1.511 . . . . 75.310000000000002 114.668 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.2 151.04 25.95 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.84 0.856 . . . . 74.340000000000003 110.245 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -81.58 137.14 35.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 117.033 2.234 . . . . 73.549999999999997 117.033 -166.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -63.34 166.44 6.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 116.017 1.858 . . . . 74.409999999999997 116.017 -175.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--O 1.253 1.287 1 N-CA-C 99.241 -4.355 . . . . 72.329999999999998 99.241 164.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.157 1 N-CA-C 96.26 -6.736 . . . . 64.129999999999995 96.26 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -135.92 99.62 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 121.531 2.666 . . . . 63.240000000000002 113.339 167.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 178.02 47.36 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 109.106 -1.597 . . . . 71.510000000000005 109.106 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.85 106.74 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.669 1.235 . . . . 75.349999999999994 111.558 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.22 178.07 0.84 Allowed Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 102.884 -3.006 . . . . 73.219999999999999 102.884 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.61 -173.2 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 116.555 -1.83 . . . . 73.319999999999993 113.19 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -51.28 153.15 2.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 118.379 2.733 . . . . 73.230000000000004 118.379 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.251 38.0 t0 -155.69 166.96 31.92 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 126.996 2.118 . . . . 72.430000000000007 108.98 -170.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m -62.57 -22.8 66.63 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.333 1.605 . . . . 72.129999999999995 115.333 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -119.51 29.56 7.55 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.155 1.455 . . . . 75.400000000000006 109.765 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -89.57 0.52 Allowed Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.13 -0.941 . . . . 52.439999999999998 114.925 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.31 142.03 50.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.009 -1.108 . . . . 72.349999999999994 108.009 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.89 150.91 39.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 120.24 3.422 . . . . 74.310000000000002 120.24 -158.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -73.19 159.58 33.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.246 -1.343 . . . . 73.219999999999999 112.738 -171.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.6 t80 . . . . . 0 C--O 1.254 1.295 1 N-CA-C 99.272 -4.344 . . . . 61.530000000000001 99.272 161.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 N-CA-C 106.828 -2.509 . . . . 72.200000000000003 106.828 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -126.08 67.73 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.716 1.258 . . . . 73.329999999999998 113.314 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.16 -177.68 48.43 Favored Glycine 0 C--O 1.221 -0.703 0 C-N-CA 118.999 -1.572 . . . . 74.349999999999994 116.654 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 103.4 11.87 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.943 -0.739 . . . . 74.310000000000002 112.482 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.61 173.32 2.31 Favored Pre-proline 0 N--CA 1.47 0.567 0 N-CA-C 101.783 -3.414 . . . . 73.140000000000001 101.783 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 -163.0 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 117.712 -1.058 . . . . 74.510000000000005 113.189 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.35 142.26 5.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 118.829 2.9 . . . . 72.109999999999999 118.829 -168.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -142.07 168.96 18.51 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 111.357 -2.656 . . . . 71.409999999999997 107.345 -173.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -71.52 -13.32 61.76 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 119.812 -1.805 . . . . 74.030000000000001 112.257 172.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -122.8 38.99 4.05 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 123.625 1.679 . . . . 72.219999999999999 108.625 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.62 -79.19 1.16 Allowed Glycine 0 C--O 1.222 -0.613 0 CA-C-O 117.672 -1.627 . . . . 74.439999999999998 115.652 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.04 137.73 49.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.801 1.801 . . . . 75.030000000000001 110.35 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.88 148.94 26.01 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 120.051 3.352 . . . . 74.450000000000003 120.051 -161.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -77.77 -179.05 5.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.541 0.737 . . . . 73.120000000000005 109.98 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.255 1.359 1 N-CA-C 98.678 -4.564 . . . . 73.519999999999996 98.678 167.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.564 0 N-CA-C 107.294 -2.322 . . . . 74.340000000000003 107.294 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . 0.414 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 56.9 m-85 -128.65 78.26 1.83 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.059 0.93 . . . . 73.530000000000001 110.122 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.04 178.85 44.28 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.651 -1.261 . . . . 73.400000000000006 114.506 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.77 108.21 18.61 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.325 -0.514 . . . . 64.319999999999993 109.707 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 174.57 1.71 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 100.553 -3.869 . . . . 73.299999999999997 100.553 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.04 -157.74 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 116.689 -1.741 . . . . 73.5 112.818 171.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.0 mt -50.53 145.06 6.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 118.605 2.817 . . . . 75.239999999999995 118.605 -167.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -138.38 171.35 14.51 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 128.391 2.677 . . . . 72.230000000000004 106.886 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m -66.39 -27.37 67.81 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 119.542 -1.974 . . . . 74.510000000000005 112.985 163.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -107.9 37.99 2.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.157 1.456 . . . . 74.120000000000005 108.841 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.3 -74.49 2.13 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-O 117.412 -1.771 . . . . 61.32 117.457 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -130.16 137.87 50.33 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.284 2.042 . . . . 71.329999999999998 109.816 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.02 153.19 21.47 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 119.88 3.289 . . . . 74.150000000000006 119.88 -159.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 2' ' ' PHE . 43.6 p90 -80.44 176.51 9.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.115 0.566 . . . . 74.239999999999995 110.773 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.2 t80 . . . . . 0 C--O 1.255 1.384 1 N-CA-C 98.454 -4.647 . . . . 64.530000000000001 98.454 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 N-CA-C 106.782 -2.527 . . . . 73.019999999999996 106.782 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -127.83 72.28 1.4 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.415 1.108 . . . . 75.329999999999998 112.578 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.93 -176.24 47.53 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.976 1.551 . . . . 72.099999999999994 116.976 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.49 96.47 8.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.974 -0.721 . . . . 75.099999999999994 112.69 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.98 172.39 4.6 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 102.266 -3.235 . . . . 74.230000000000004 102.266 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.0 -158.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.833 0.976 . . . . 75.0 112.554 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.9 mt -46.99 144.8 2.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 119.017 2.969 . . . . 74.019999999999996 119.017 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -151.33 165.73 33.15 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 111.284 -2.689 . . . . 74.25 107.202 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 m -64.75 -24.18 67.48 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 120.665 -1.272 . . . . 74.329999999999998 113.047 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -115.8 38.73 3.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 123.629 1.68 . . . . 75.349999999999994 109.065 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.4 -76.47 1.28 Allowed Glycine 0 C--O 1.226 -0.378 0 CA-C-O 117.837 -1.535 . . . . 55.32 116.524 174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.14 136.06 49.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.648 1.724 . . . . 71.420000000000002 110.561 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -84.68 151.43 24.45 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 120.706 3.595 . . . . 73.519999999999996 120.706 -160.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -82.57 -178.71 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.303 0.641 . . . . 75.209999999999994 110.06 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 t80 . . . . . 0 C--O 1.255 1.39 1 N-CA-C 98.725 -4.546 . . . . 74.450000000000003 98.725 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.104 1 N-CA-C 97.051 -6.42 . . . . 60.43 97.051 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -134.43 110.66 9.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 121.328 2.564 . . . . 74.230000000000004 111.109 165.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.56 -174.81 43.89 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.068 -0.813 . . . . 74.129999999999995 111.068 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 80.76 9.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.331 1.234 . . . . 74.049999999999997 114.331 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.97 171.04 7.97 Favored Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 105.655 -1.98 . . . . 74.420000000000002 105.655 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.61 -162.26 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.765 0 CA-C-N 119.759 0.95 . . . . 61.520000000000003 112.925 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -48.82 148.65 2.1 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 120.144 3.387 . . . . 63.450000000000003 120.144 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -155.11 167.59 29.85 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 111.785 -2.461 . . . . 71.420000000000002 108.418 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -64.76 -22.99 67.1 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.643 -1.286 . . . . 72.409999999999997 114.291 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -117.04 30.58 7.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.811 1.767 . . . . 72.409999999999997 109.071 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.59 -80.94 0.34 Allowed Glycine 0 C--O 1.225 -0.448 0 CA-C-O 118.394 -1.225 . . . . 73.209999999999994 116.083 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.62 130.75 47.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.087 1.443 . . . . 75.439999999999998 110.189 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.04 149.59 44.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 119.399 3.111 . . . . 74.319999999999993 119.399 -160.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -74.74 174.56 8.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.949 -1.023 . . . . 72.25 111.638 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.3 p90 . . . . . 0 C--O 1.253 1.283 1 N-CA-C 99.922 -4.103 . . . . 74.120000000000005 99.922 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 N-CA-C 108.777 -1.729 . . . . 74.310000000000002 108.777 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -161.74 154.02 19.71 Favored 'General case' 0 C--N 1.324 -0.512 1 N-CA-C 100.114 -4.032 . . . . 75.420000000000002 100.114 150.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.89 -158.33 27.65 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 120.905 1.684 . . . . 55.520000000000003 116.493 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 p -117.36 12.14 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.066 1.876 . . . . 72.120000000000005 116.066 -169.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.25 165.56 12.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 106.864 -1.532 . . . . 75.010000000000005 106.864 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.03 -176.56 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 119.384 0.816 . . . . 73.400000000000006 113.017 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.7 mt -51.96 134.15 32.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 118.275 2.694 . . . . 73.120000000000005 118.275 -147.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -99.63 174.47 6.22 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 111.985 -2.371 . . . . 63.0 105.696 171.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 t -65.8 -24.02 66.83 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.985 -1.697 . . . . 71.030000000000001 110.868 164.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -123.13 81.81 1.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.893 1.33 . . . . 73.310000000000002 109.622 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.17 -106.94 2.29 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.516 -0.85 . . . . 75.420000000000002 115.117 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.53 154.02 35.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.566 -0.901 . . . . 64.129999999999995 108.566 -173.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -96.07 152.34 18.63 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 117.475 2.398 . . . . 73.420000000000002 117.475 -166.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -69.72 179.3 2.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.497 -1.229 . . . . 75.109999999999999 113.349 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.4 p90 . . . . . 0 C--O 1.255 1.343 1 N-CA-C 98.94 -4.467 . . . . 73.209999999999994 98.94 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.132 1 N-CA-C 101.545 -4.622 . . . . 53.450000000000003 101.545 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.48 106.75 5.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.93 1.865 . . . . 75.329999999999998 111.367 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.89 172.33 43.92 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 107.497 -2.241 . . . . 63.520000000000003 107.497 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.95 113.25 20.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.512 1.156 . . . . 74.129999999999995 110.525 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -175.36 -179.64 0.39 Allowed Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 101.715 -3.439 . . . . 74.319999999999993 101.715 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.62 -170.69 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 117.03 -1.513 . . . . 73.150000000000006 112.601 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.46 145.19 11.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 116.292 1.96 . . . . 75.030000000000001 116.292 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.304 17.6 t0 -99.93 -163.17 1.01 Allowed 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 127.837 2.455 . . . . 73.430000000000007 108.22 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -67.02 -31.19 71.56 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.656 -2.528 . . . . 71.209999999999994 114.796 159.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -147.56 128.45 14.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.943 -2.614 . . . . 74.040000000000006 103.943 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.24 -150.57 37.26 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 119.627 -1.273 . . . . 41.0 112.732 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.1 mt -114.34 143.81 44.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.047 -1.094 . . . . 74.420000000000002 108.047 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -64.49 136.9 57.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.261 1.578 . . . . 73.329999999999998 115.261 -163.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -62.05 168.54 3.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.377 -1.283 . . . . 75.400000000000006 112.683 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 17.3 t80 . . . . . 0 C--O 1.253 1.269 1 N-CA-C 97.736 -4.913 . . . . 73.120000000000005 97.736 172.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.352 1 N-CA-C 97.131 -6.388 . . . . 75.329999999999998 97.131 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -131.05 105.76 7.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.625 2.213 . . . . 74.420000000000002 110.955 165.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.02 -176.2 45.83 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 108.658 -1.777 . . . . 75.439999999999998 108.658 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.42 105.06 17.55 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 115.295 1.591 . . . . 54.43 115.295 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.432 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.3 OUTLIER -177.54 175.4 0.56 Allowed Pre-proline 0 N--CA 1.478 0.968 0 N-CA-C 101.116 -3.661 . . . . 75.329999999999998 101.116 166.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.69 -164.16 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 CA-C-N 120.753 1.305 . . . . 74.409999999999997 114.902 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.4 mt -47.45 145.65 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 120.217 3.414 . . . . 72.219999999999999 120.217 -166.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -155.56 168.95 25.46 Favored 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 127.745 2.418 . . . . 74.120000000000005 107.958 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -58.56 -37.3 75.44 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.94 1.089 . . . . 71.420000000000002 113.94 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -106.12 30.3 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.265 1.507 . . . . 72.140000000000001 109.846 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.27 -77.84 0.23 Allowed Glycine 0 C--O 1.226 -0.386 0 CA-C-O 118.389 -1.228 . . . . 73.329999999999998 115.141 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.35 137.63 48.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.286 1.543 . . . . 73.219999999999999 112.361 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.4 130.86 43.69 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.56 2.059 . . . . 73.040000000000006 116.56 -166.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -79.51 170.24 16.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 73.299999999999997 111.65 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.432 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 46.8 t80 . . . . . 0 C--O 1.254 1.336 1 N-CA-C 99.14 -4.392 . . . . 73.340000000000003 99.14 165.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 0.065 1 N-CA-C 98.529 -5.828 . . . . 72.420000000000002 98.529 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -132.47 93.1 3.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.131 2.465 . . . . 75.219999999999999 112.526 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.74 -176.45 45.76 Favored Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.699 -1.76 . . . . 73.209999999999994 108.699 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.91 104.64 16.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 115.913 1.82 . . . . 73.099999999999994 115.913 -175.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -177.0 174.89 0.63 Allowed Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 100.828 -3.768 . . . . 74.430000000000007 100.828 166.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.82 -164.61 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 120.808 1.324 . . . . 73.310000000000002 115.461 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -47.21 144.66 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 119.669 3.211 . . . . 73.25 119.669 -167.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -156.54 166.11 34.34 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 127.484 2.314 . . . . 70.439999999999998 108.096 -169.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -28.26 67.85 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 116.398 1.999 . . . . 73.349999999999994 116.398 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -114.03 27.67 9.34 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 123.309 1.528 . . . . 62.439999999999998 109.202 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.49 -79.52 0.26 Allowed Glycine 0 C--O 1.226 -0.358 0 CA-C-O 118.499 -1.167 . . . . 73.5 115.193 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.51 136.4 47.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.119 1.459 . . . . 73.540000000000006 112.827 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.04 133.15 46.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.565 2.061 . . . . 62.310000000000002 116.565 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -88.18 170.59 10.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 70.219999999999999 111.071 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 C--O 1.256 1.426 1 N-CA-C 98.453 -4.647 . . . . 73.329999999999998 98.453 167.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.135 0 N-CA-C 103.719 -3.752 . . . . 60.109999999999999 103.719 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -138.06 110.39 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.002 1.401 . . . . 70.530000000000001 110.409 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.64 167.95 37.15 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 107.398 -2.281 . . . . 41.520000000000003 107.398 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.21 109.73 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.895 1.347 . . . . 74.319999999999993 109.954 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.417 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -173.81 178.27 0.61 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 102.439 -3.171 . . . . 74.340000000000003 102.439 -178.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.2 -173.48 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 116.718 -1.722 . . . . 74.200000000000003 112.379 167.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.2 mt -50.72 139.28 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 115.849 1.796 . . . . 75.329999999999998 115.849 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.268 7.7 t0 -85.21 -164.77 1.05 Allowed 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 112.115 -2.311 . . . . 64.310000000000002 107.502 168.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -65.79 -33.33 75.61 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.801 -2.437 . . . . 71.239999999999995 113.413 160.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -153.68 129.14 9.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 103.899 -2.63 . . . . 75.409999999999997 103.899 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.29 -156.92 26.41 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.757 -0.735 . . . . 72.040000000000006 111.384 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.0 mt -118.63 142.08 47.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.095 -1.817 . . . . 74.129999999999995 106.095 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -61.94 135.07 57.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.966 1.469 . . . . 74.310000000000002 114.966 -162.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -62.99 172.23 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.241 -1.345 . . . . 73.519999999999996 113.607 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 72.3 t80 . . . . . 0 C--O 1.254 1.324 1 N-CA-C 98.521 -4.622 . . . . 71.530000000000001 98.521 169.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.152 1 N-CA-C 101.165 -4.774 . . . . 73.329999999999998 101.165 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -106.78 150.05 26.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 101.284 -3.599 . . . . 75.209999999999994 101.284 161.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.39 -161.19 27.06 Favored Glycine 0 C--O 1.222 -0.609 0 CA-C-N 119.55 1.068 . . . . 74.109999999999999 112.242 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 p -108.88 -6.98 15.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.679 1.362 . . . . 64.420000000000002 114.679 -170.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -133.5 163.07 53.75 Favored Pre-proline 0 C--O 1.218 -0.572 0 N-CA-C 105.805 -1.924 . . . . 73.319999999999993 105.805 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.66 172.13 15.84 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 115.83 -2.314 . . . . 73.209999999999994 113.892 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . 0.411 2.5 pp 68.45 111.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 121.224 3.787 . . . . 73.319999999999993 121.224 169.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -174.8 168.78 3.59 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 100.923 -3.732 . . . . 72.439999999999998 100.923 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -68.82 -25.76 64.83 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 121.274 1.852 . . . . 75.349999999999994 111.639 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -99.45 15.23 27.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 123.006 1.384 . . . . 71.549999999999997 109.432 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.39 -36.74 4.01 Favored Glycine 0 N--CA 1.454 -0.134 0 N-CA-C 119.688 2.635 . . . . 73.319999999999993 119.688 170.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.06 128.28 43.24 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 116.943 2.201 . . . . 73.430000000000007 116.943 -173.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -72.0 132.44 44.28 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.048 -1.033 . . . . 74.239999999999995 111.8 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -99.56 133.62 43.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 63.210000000000001 111.949 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.1 t80 . . . . . 0 C--O 1.263 1.775 1 N-CA-C 95.979 -5.563 . . . . 75.540000000000006 95.979 161.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.31 0 N-CA-C 106.38 -2.688 . . . . 61.520000000000003 106.38 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -127.47 137.2 52.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 102.922 -2.992 . . . . 74.400000000000006 102.922 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.46 -169.4 41.89 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 107.735 -2.146 . . . . 65.430000000000007 107.735 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.1 p -97.41 -7.96 30.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 115.266 1.58 . . . . 72.310000000000002 115.266 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -102.69 157.03 34.53 Favored Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 121.745 -0.597 . . . . 73.420000000000002 111.129 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.94 176.49 7.59 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 116.46 -1.893 . . . . 72.099999999999994 112.138 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pp 40.68 74.04 0.11 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 118.74 2.867 . . . . 74.230000000000004 118.74 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -70.16 -174.16 0.77 Allowed 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.528 -1.358 . . . . 75.25 108.411 151.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -59.98 -36.06 76.35 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.499 -2.001 . . . . 75.040000000000006 113.184 162.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.53 132.79 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 102.554 -3.128 . . . . 74.219999999999999 102.554 167.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.55 -153.53 21.71 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 119.076 0.853 . . . . 63.399999999999999 113.556 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.03 136.84 47.04 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.326 0.65 . . . . 74.549999999999997 110.326 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.9 123.95 23.81 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.113 -0.992 . . . . 74.230000000000004 112.991 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -62.69 158.62 18.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.453 -1.703 . . . . 75.200000000000003 112.99 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.6 t80 . . . . . 0 C--O 1.256 1.447 1 N-CA-C 99.548 -4.241 . . . . 74.409999999999997 99.548 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.372 0 N-CA-C 104.251 -3.54 . . . . 73.049999999999997 104.251 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -138.59 125.01 20.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.02 -2.215 . . . . 73.129999999999995 105.02 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.86 -162.52 30.25 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.913 -0.875 . . . . 63.009999999999998 110.913 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.9 p -100.72 -2.06 33.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.867 2.173 . . . . 72.209999999999994 116.867 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 163.04 20.3 Favored Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 121.335 -0.853 . . . . 74.400000000000006 109.599 -174.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.0 178.13 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 119.08 0.707 . . . . 74.530000000000001 112.598 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.6 mt -50.91 135.26 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 118.551 2.797 . . . . 73.040000000000006 118.551 -149.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.305 5.9 t0 -78.88 -164.11 0.56 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 110.88 -2.873 . . . . 64.019999999999996 108.467 171.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.7 p -65.78 -33.59 76.21 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 118.404 -2.685 . . . . 74.129999999999995 113.692 160.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -147.28 128.87 15.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.558 -2.386 . . . . 75.329999999999998 104.558 173.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.65 -159.31 44.14 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 119.889 1.222 . . . . 72.230000000000004 113.86 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.4 147.0 23.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.119 0.568 . . . . 74.239999999999995 109.549 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -72.02 128.78 36.79 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 115.266 1.58 . . . . 75.439999999999998 115.266 -169.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -62.48 158.64 17.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.0 -1.909 . . . . 75.200000000000003 114.499 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--O 1.253 1.25 1 N-CA-C 99.353 -4.314 . . . . 73.109999999999999 99.353 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.606 0 N-CA-C 105.143 -3.183 . . . . 71.120000000000005 105.143 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -147.08 118.71 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.742 -1.577 . . . . 75.540000000000006 106.742 150.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.19 -158.65 28.43 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.103 1.201 . . . . 45.219999999999999 116.103 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.4 p -91.38 2.96 56.03 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 119.494 3.146 . . . . 74.310000000000002 119.494 -169.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HZ2' ' HB2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -104.52 170.16 6.37 Favored Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 121.073 -1.017 . . . . 74.439999999999998 108.299 -177.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -64.31 -172.23 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 119.76 0.95 . . . . 61.310000000000002 113.895 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 mp -48.31 134.89 14.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 117.715 2.487 . . . . 75.109999999999999 117.715 -165.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.324 23.1 t0 -100.73 -165.75 1.24 Allowed 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 128.989 2.916 . . . . 74.420000000000002 109.142 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -31.01 70.32 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 119.204 -2.185 . . . . 61.399999999999999 115.364 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -147.91 127.11 12.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.796 -1.928 . . . . 72.340000000000003 105.796 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 -144.36 43.24 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 119.056 -1.545 . . . . 75.129999999999995 113.864 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.81 146.89 26.71 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.636 0.774 . . . . 73.430000000000007 110.433 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -73.62 134.85 43.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 116.369 1.988 . . . . 75.409999999999997 116.369 -168.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -60.49 158.92 11.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.066 -1.879 . . . . 75.109999999999999 113.681 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--O 1.252 1.203 1 N-CA-C 97.751 -4.907 . . . . 75.209999999999994 97.751 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.699 0 N-CA-C 106.533 -2.627 . . . . 73.450000000000003 106.533 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -148.71 137.07 21.14 Favored 'General case' 0 C--N 1.322 -0.603 1 N-CA-C 100.131 -4.026 . . . . 74.019999999999996 100.131 140.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.28 -158.49 31.14 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 120.529 1.513 . . . . 73.230000000000004 116.624 -173.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.3 p -104.7 -3.83 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 118.269 2.692 . . . . 75.099999999999994 118.269 -172.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HZ2' ' HB2' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -96.47 170.81 6.94 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 105.837 -1.912 . . . . 74.310000000000002 105.837 -177.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -64.93 -167.92 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 N-CA-C 115.154 1.175 . . . . 71.340000000000003 115.154 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -47.24 133.18 12.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 116.75 2.13 . . . . 72.310000000000002 116.75 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.288 27.0 t0 -107.59 -169.34 1.51 Allowed 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 111.724 -2.489 . . . . 74.420000000000002 108.563 -173.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -62.17 -31.77 72.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 119.366 -2.084 . . . . 75.219999999999999 113.929 159.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -141.71 120.6 12.75 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 108.252 -1.018 . . . . 73.120000000000005 108.252 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.81 -133.54 32.01 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 119.126 -1.511 . . . . 75.310000000000002 114.668 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.2 151.04 25.95 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.84 0.856 . . . . 74.340000000000003 110.245 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -81.58 137.14 35.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 117.033 2.234 . . . . 73.549999999999997 117.033 -166.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -63.34 166.44 6.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 116.017 1.858 . . . . 74.409999999999997 116.017 -175.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--O 1.253 1.287 1 N-CA-C 99.241 -4.355 . . . . 72.329999999999998 99.241 164.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.157 1 N-CA-C 96.26 -6.736 . . . . 64.129999999999995 96.26 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -135.92 99.62 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 121.531 2.666 . . . . 63.240000000000002 113.339 167.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 178.02 47.36 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 109.106 -1.597 . . . . 71.510000000000005 109.106 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.85 106.74 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.669 1.235 . . . . 75.349999999999994 111.558 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.22 178.07 0.84 Allowed Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 102.884 -3.006 . . . . 73.219999999999999 102.884 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.61 -173.2 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 116.555 -1.83 . . . . 73.319999999999993 113.19 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -51.28 153.15 2.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 118.379 2.733 . . . . 73.230000000000004 118.379 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.251 38.0 t0 -155.69 166.96 31.92 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 126.996 2.118 . . . . 72.430000000000007 108.98 -170.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m -62.57 -22.8 66.63 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.333 1.605 . . . . 72.129999999999995 115.333 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -119.51 29.56 7.55 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.155 1.455 . . . . 75.400000000000006 109.765 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -89.57 0.52 Allowed Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.13 -0.941 . . . . 52.439999999999998 114.925 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.31 142.03 50.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.009 -1.108 . . . . 72.349999999999994 108.009 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.89 150.91 39.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 120.24 3.422 . . . . 74.310000000000002 120.24 -158.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -73.19 159.58 33.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.246 -1.343 . . . . 73.219999999999999 112.738 -171.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.6 t80 . . . . . 0 C--O 1.254 1.295 1 N-CA-C 99.272 -4.344 . . . . 61.530000000000001 99.272 161.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 N-CA-C 106.828 -2.509 . . . . 72.200000000000003 106.828 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -126.08 67.73 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.716 1.258 . . . . 73.329999999999998 113.314 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.16 -177.68 48.43 Favored Glycine 0 C--O 1.221 -0.703 0 C-N-CA 118.999 -1.572 . . . . 74.349999999999994 116.654 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 103.4 11.87 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.943 -0.739 . . . . 74.310000000000002 112.482 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.61 173.32 2.31 Favored Pre-proline 0 N--CA 1.47 0.567 0 N-CA-C 101.783 -3.414 . . . . 73.140000000000001 101.783 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 -163.0 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 117.712 -1.058 . . . . 74.510000000000005 113.189 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.35 142.26 5.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 118.829 2.9 . . . . 72.109999999999999 118.829 -168.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -142.07 168.96 18.51 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 111.357 -2.656 . . . . 71.409999999999997 107.345 -173.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -71.52 -13.32 61.76 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 119.812 -1.805 . . . . 74.030000000000001 112.257 172.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -122.8 38.99 4.05 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 123.625 1.679 . . . . 72.219999999999999 108.625 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.62 -79.19 1.16 Allowed Glycine 0 C--O 1.222 -0.613 0 CA-C-O 117.672 -1.627 . . . . 74.439999999999998 115.652 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.04 137.73 49.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.801 1.801 . . . . 75.030000000000001 110.35 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.88 148.94 26.01 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 120.051 3.352 . . . . 74.450000000000003 120.051 -161.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -77.77 -179.05 5.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.541 0.737 . . . . 73.120000000000005 109.98 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.255 1.359 1 N-CA-C 98.678 -4.564 . . . . 73.519999999999996 98.678 167.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.564 0 N-CA-C 107.294 -2.322 . . . . 74.340000000000003 107.294 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.414 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 56.9 m-85 -128.65 78.26 1.83 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.059 0.93 . . . . 73.530000000000001 110.122 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.04 178.85 44.28 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.651 -1.261 . . . . 73.400000000000006 114.506 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.77 108.21 18.61 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.325 -0.514 . . . . 64.319999999999993 109.707 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 174.57 1.71 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 100.553 -3.869 . . . . 73.299999999999997 100.553 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.04 -157.74 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 116.689 -1.741 . . . . 73.5 112.818 171.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.0 mt -50.53 145.06 6.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 118.605 2.817 . . . . 75.239999999999995 118.605 -167.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -138.38 171.35 14.51 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 128.391 2.677 . . . . 72.230000000000004 106.886 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m -66.39 -27.37 67.81 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 119.542 -1.974 . . . . 74.510000000000005 112.985 163.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -107.9 37.99 2.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.157 1.456 . . . . 74.120000000000005 108.841 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.3 -74.49 2.13 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-O 117.412 -1.771 . . . . 61.32 117.457 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -130.16 137.87 50.33 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.284 2.042 . . . . 71.329999999999998 109.816 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.02 153.19 21.47 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 119.88 3.289 . . . . 74.150000000000006 119.88 -159.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 2' ' ' PHE . 43.6 p90 -80.44 176.51 9.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.115 0.566 . . . . 74.239999999999995 110.773 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.2 t80 . . . . . 0 C--O 1.255 1.384 1 N-CA-C 98.454 -4.647 . . . . 64.530000000000001 98.454 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 N-CA-C 106.782 -2.527 . . . . 73.019999999999996 106.782 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -127.83 72.28 1.4 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.415 1.108 . . . . 75.329999999999998 112.578 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.93 -176.24 47.53 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.976 1.551 . . . . 72.099999999999994 116.976 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.49 96.47 8.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.974 -0.721 . . . . 75.099999999999994 112.69 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.98 172.39 4.6 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 102.266 -3.235 . . . . 74.230000000000004 102.266 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.0 -158.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.833 0.976 . . . . 75.0 112.554 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.9 mt -46.99 144.8 2.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 119.017 2.969 . . . . 74.019999999999996 119.017 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -151.33 165.73 33.15 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 111.284 -2.689 . . . . 74.25 107.202 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 m -64.75 -24.18 67.48 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 120.665 -1.272 . . . . 74.329999999999998 113.047 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -115.8 38.73 3.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 123.629 1.68 . . . . 75.349999999999994 109.065 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.4 -76.47 1.28 Allowed Glycine 0 C--O 1.226 -0.378 0 CA-C-O 117.837 -1.535 . . . . 55.32 116.524 174.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.14 136.06 49.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.648 1.724 . . . . 71.420000000000002 110.561 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -84.68 151.43 24.45 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 120.706 3.595 . . . . 73.519999999999996 120.706 -160.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -82.57 -178.71 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.303 0.641 . . . . 75.209999999999994 110.06 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 t80 . . . . . 0 C--O 1.255 1.39 1 N-CA-C 98.725 -4.546 . . . . 74.450000000000003 98.725 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.104 1 N-CA-C 97.051 -6.42 . . . . 45.03 97.051 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -134.43 110.66 9.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 121.328 2.564 . . . . 72.54 111.109 165.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.56 -174.81 43.89 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.068 -0.813 . . . . 74.13 111.068 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 80.76 9.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.331 1.234 . . . . 74.05 114.331 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.97 171.04 7.97 Favored Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 105.655 -1.98 . . . . 74.42 105.655 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.61 -162.26 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.765 0 CA-C-N 119.759 0.95 . . . . 61.52 112.925 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -48.82 148.65 2.1 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 120.144 3.387 . . . . 63.45 120.144 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -155.11 167.59 29.85 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 111.785 -2.461 . . . . 71.42 108.418 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -64.76 -22.99 67.1 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.643 -1.286 . . . . 30.13 114.291 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -117.04 30.58 7.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.811 1.767 . . . . 53.03 109.071 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.59 -80.94 0.34 Allowed Glycine 0 C--O 1.225 -0.448 0 CA-C-O 118.394 -1.225 . . . . 73.21 116.083 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.62 130.75 47.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.087 1.443 . . . . 75.44 110.189 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.04 149.59 44.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 119.399 3.111 . . . . 71.31 119.399 -160.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -74.74 174.56 8.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.949 -1.023 . . . . 65.12 111.638 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.3 p90 . . . . . 0 C--O 1.253 1.283 1 N-CA-C 99.922 -4.103 . . . . 64.04 99.922 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 N-CA-C 108.777 -1.729 . . . . 74.31 108.777 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -161.74 154.02 19.71 Favored 'General case' 0 C--N 1.324 -0.512 1 N-CA-C 100.114 -4.032 . . . . 75.42 100.114 150.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.89 -158.33 27.65 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 120.905 1.684 . . . . 55.52 116.493 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 p -117.36 12.14 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.066 1.876 . . . . 72.12 116.066 -169.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.25 165.56 12.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 106.864 -1.532 . . . . 74.12 106.864 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.03 -176.56 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 119.384 0.816 . . . . 73.4 113.017 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.7 mt -51.96 134.15 32.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 118.275 2.694 . . . . 72.25 118.275 -147.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -99.63 174.47 6.22 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 111.985 -2.371 . . . . 63.0 105.696 171.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 t -65.8 -24.02 66.83 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.985 -1.697 . . . . 71.03 110.868 164.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -123.13 81.81 1.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.893 1.33 . . . . 72.43 109.622 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.17 -106.94 2.29 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.516 -0.85 . . . . 75.42 115.117 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.53 154.02 35.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.566 -0.901 . . . . 61.24 108.566 -173.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -96.07 152.34 18.63 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 117.475 2.398 . . . . 72.52 117.475 -166.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -69.72 179.3 2.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.497 -1.229 . . . . 73.03 113.349 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.4 p90 . . . . . 0 C--O 1.255 1.343 1 N-CA-C 98.94 -4.467 . . . . 73.21 98.94 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.132 1 N-CA-C 101.545 -4.622 . . . . 41.52 101.545 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.48 106.75 5.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.93 1.865 . . . . 72.22 111.367 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.89 172.33 43.92 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 107.497 -2.241 . . . . 63.52 107.497 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.95 113.25 20.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.512 1.156 . . . . 74.13 110.525 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -175.36 -179.64 0.39 Allowed Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 101.715 -3.439 . . . . 74.32 101.715 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.62 -170.69 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 117.03 -1.513 . . . . 73.15 112.601 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.46 145.19 11.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 116.292 1.96 . . . . 73.2 116.292 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.304 17.6 t0 -99.93 -163.17 1.01 Allowed 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 127.837 2.455 . . . . 73.43 108.22 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -67.02 -31.19 71.56 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.656 -2.528 . . . . 71.21 114.796 159.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -147.56 128.45 14.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.943 -2.614 . . . . 74.04 103.943 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.24 -150.57 37.26 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 119.627 -1.273 . . . . 30.01 112.732 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.1 mt -114.34 143.81 44.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.047 -1.094 . . . . 64.32 108.047 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -64.49 136.9 57.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.261 1.578 . . . . 73.3 115.261 -163.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -62.05 168.54 3.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.377 -1.283 . . . . 75.34 112.683 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 17.3 t80 . . . . . 0 C--O 1.253 1.269 1 N-CA-C 97.736 -4.913 . . . . 72.3 97.736 172.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.352 1 N-CA-C 97.131 -6.388 . . . . 75.33 97.131 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -131.05 105.76 7.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.625 2.213 . . . . 74.42 110.955 165.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.02 -176.2 45.83 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 108.658 -1.777 . . . . 75.44 108.658 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.42 105.06 17.55 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 115.295 1.591 . . . . 51.33 115.295 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.3 OUTLIER -177.54 175.4 0.56 Allowed Pre-proline 0 N--CA 1.478 0.968 0 N-CA-C 101.116 -3.661 . . . . 73.41 101.116 166.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.69 -164.16 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 CA-C-N 120.753 1.305 . . . . 71.14 114.902 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.4 mt -47.45 145.65 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 120.217 3.414 . . . . 72.22 120.217 -166.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -155.56 168.95 25.46 Favored 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 127.745 2.418 . . . . 74.12 107.958 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -58.56 -37.3 75.44 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.94 1.089 . . . . 71.42 113.94 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -106.12 30.3 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.265 1.507 . . . . 72.14 109.846 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.27 -77.84 0.23 Allowed Glycine 0 C--O 1.226 -0.386 0 CA-C-O 118.389 -1.228 . . . . 54.12 115.141 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.35 137.63 48.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.286 1.543 . . . . 73.22 112.361 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.4 130.86 43.69 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.56 2.059 . . . . 73.04 116.56 -166.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -79.51 170.24 16.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 54.32 111.65 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 46.8 t80 . . . . . 0 C--O 1.254 1.336 1 N-CA-C 99.14 -4.392 . . . . 73.34 99.14 165.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 0.065 1 N-CA-C 98.529 -5.828 . . . . 72.42 98.529 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -132.47 93.1 3.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.131 2.465 . . . . 74.51 112.526 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.74 -176.45 45.76 Favored Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.699 -1.76 . . . . 72.35 108.699 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.91 104.64 16.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 115.913 1.82 . . . . 73.1 115.913 -175.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -177.0 174.89 0.63 Allowed Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 100.828 -3.768 . . . . 71.41 100.828 166.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.82 -164.61 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 120.808 1.324 . . . . 73.31 115.461 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -47.21 144.66 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 119.669 3.211 . . . . 73.25 119.669 -167.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -156.54 166.11 34.34 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 127.484 2.314 . . . . 70.44 108.096 -169.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -28.26 67.85 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 116.398 1.999 . . . . 73.35 116.398 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -114.03 27.67 9.34 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 123.309 1.528 . . . . 62.44 109.202 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.49 -79.52 0.26 Allowed Glycine 0 C--O 1.226 -0.358 0 CA-C-O 118.499 -1.167 . . . . 73.5 115.193 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.51 136.4 47.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.119 1.459 . . . . 70.34 112.827 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.04 133.15 46.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.565 2.061 . . . . 62.31 116.565 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -88.18 170.59 10.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 63.35 111.071 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 C--O 1.256 1.426 1 N-CA-C 98.453 -4.647 . . . . 71.34 98.453 167.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.135 0 N-CA-C 103.719 -3.752 . . . . 60.11 103.719 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -138.06 110.39 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.002 1.401 . . . . 70.53 110.409 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.64 167.95 37.15 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 107.398 -2.281 . . . . 41.52 107.398 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.21 109.73 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.895 1.347 . . . . 74.32 109.954 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.81 178.27 0.61 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 102.439 -3.171 . . . . 72.22 102.439 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.2 -173.48 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 116.718 -1.722 . . . . 74.2 112.379 167.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.2 mt -50.72 139.28 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 115.849 1.796 . . . . 73.54 115.849 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.268 7.7 t0 -85.21 -164.77 1.05 Allowed 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 112.115 -2.311 . . . . 64.31 107.502 168.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -65.79 -33.33 75.61 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.801 -2.437 . . . . 71.24 113.413 160.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -153.68 129.14 9.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 103.899 -2.63 . . . . 75.41 103.899 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.29 -156.92 26.41 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.757 -0.735 . . . . 72.04 111.384 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.0 mt -118.63 142.08 47.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.095 -1.817 . . . . 72.14 106.095 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -61.94 135.07 57.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.966 1.469 . . . . 74.31 114.966 -162.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -62.99 172.23 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.241 -1.345 . . . . 73.52 113.607 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.3 t80 . . . . . 0 C--O 1.254 1.324 1 N-CA-C 98.521 -4.622 . . . . 71.53 98.521 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.152 1 N-CA-C 101.165 -4.774 . . . . 73.33 101.165 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -106.78 150.05 26.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 101.284 -3.599 . . . . 74.44 101.284 161.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.39 -161.19 27.06 Favored Glycine 0 C--O 1.222 -0.609 0 CA-C-N 119.55 1.068 . . . . 72.11 112.242 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 p -108.88 -6.98 15.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.679 1.362 . . . . 61.45 114.679 -170.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -133.5 163.07 53.75 Favored Pre-proline 0 C--O 1.218 -0.572 0 N-CA-C 105.805 -1.924 . . . . 73.32 105.805 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.66 172.13 15.84 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 115.83 -2.314 . . . . 73.11 113.892 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . 0.411 2.5 pp 68.45 111.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 121.224 3.787 . . . . 73.32 121.224 169.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -174.8 168.78 3.59 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 100.923 -3.732 . . . . 65.21 100.923 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -68.82 -25.76 64.83 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 121.274 1.852 . . . . 63.24 111.639 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -99.45 15.23 27.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 123.006 1.384 . . . . 63.42 109.432 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.39 -36.74 4.01 Favored Glycine 0 N--CA 1.454 -0.134 0 N-CA-C 119.688 2.635 . . . . 64.44 119.688 170.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.06 128.28 43.24 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 116.943 2.201 . . . . 64.51 116.943 -173.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -72.0 132.44 44.28 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.048 -1.033 . . . . 72.21 111.8 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -99.56 133.62 43.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 63.21 111.949 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.1 t80 . . . . . 0 C--O 1.263 1.775 1 N-CA-C 95.979 -5.563 . . . . 71.45 95.979 161.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.31 0 N-CA-C 106.38 -2.688 . . . . 42.23 106.38 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -127.47 137.2 52.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 102.922 -2.992 . . . . 74.4 102.922 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.46 -169.4 41.89 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 107.735 -2.146 . . . . 65.43 107.735 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.1 p -97.41 -7.96 30.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 115.266 1.58 . . . . 72.31 115.266 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -102.69 157.03 34.53 Favored Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 121.745 -0.597 . . . . 73.41 111.129 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.94 176.49 7.59 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 116.46 -1.893 . . . . 50.23 112.138 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pp 40.68 74.04 0.11 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 118.74 2.867 . . . . 74.23 118.74 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -70.16 -174.16 0.77 Allowed 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.528 -1.358 . . . . 75.25 108.411 151.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -59.98 -36.06 76.35 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.499 -2.001 . . . . 75.04 113.184 162.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.53 132.79 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 102.554 -3.128 . . . . 74.22 102.554 167.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.55 -153.53 21.71 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 119.076 0.853 . . . . 63.4 113.556 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.03 136.84 47.04 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.326 0.65 . . . . 71.3 110.326 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.9 123.95 23.81 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.113 -0.992 . . . . 74.23 112.991 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -62.69 158.62 18.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.453 -1.703 . . . . 75.2 112.99 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.6 t80 . . . . . 0 C--O 1.256 1.447 1 N-CA-C 99.548 -4.241 . . . . 65.15 99.548 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.372 0 N-CA-C 104.251 -3.54 . . . . 72.23 104.251 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -138.59 125.01 20.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.02 -2.215 . . . . 64.32 105.02 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.86 -162.52 30.25 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.913 -0.875 . . . . 63.01 110.913 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.9 p -100.72 -2.06 33.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.867 2.173 . . . . 72.21 116.867 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 163.04 20.3 Favored Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 121.335 -0.853 . . . . 74.35 109.599 -174.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.0 178.13 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 119.08 0.707 . . . . 63.12 112.598 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.6 mt -50.91 135.26 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 118.551 2.797 . . . . 52.32 118.551 -149.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.305 5.9 t0 -78.88 -164.11 0.56 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 110.88 -2.873 . . . . 64.02 108.467 171.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.7 p -65.78 -33.59 76.21 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 118.404 -2.685 . . . . 74.13 113.692 160.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -147.28 128.87 15.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.558 -2.386 . . . . 75.33 104.558 173.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.65 -159.31 44.14 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 119.889 1.222 . . . . 72.23 113.86 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.4 147.0 23.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.119 0.568 . . . . 74.24 109.549 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -72.02 128.78 36.79 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 115.266 1.58 . . . . 75.44 115.266 -169.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -62.48 158.64 17.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.0 -1.909 . . . . 61.12 114.499 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--O 1.253 1.25 1 N-CA-C 99.353 -4.314 . . . . 73.11 99.353 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.606 0 N-CA-C 105.143 -3.183 . . . . 71.12 105.143 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -147.08 118.71 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.742 -1.577 . . . . 75.54 106.742 150.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.19 -158.65 28.43 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.103 1.201 . . . . 43.42 116.103 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.4 p -91.38 2.96 56.03 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 119.494 3.146 . . . . 74.31 119.494 -169.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.52 170.16 6.37 Favored Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 121.073 -1.017 . . . . 72.22 108.299 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -64.31 -172.23 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 119.76 0.95 . . . . 61.31 113.895 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 mp -48.31 134.89 14.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 117.715 2.487 . . . . 73.31 117.715 -165.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.324 23.1 t0 -100.73 -165.75 1.24 Allowed 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 128.989 2.916 . . . . 62.41 109.142 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -31.01 70.32 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 119.204 -2.185 . . . . 61.04 115.364 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -147.91 127.11 12.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.796 -1.928 . . . . 65.33 105.796 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 -144.36 43.24 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 119.056 -1.545 . . . . 75.13 113.864 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.81 146.89 26.71 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.636 0.774 . . . . 73.43 110.433 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -73.62 134.85 43.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 116.369 1.988 . . . . 75.41 116.369 -168.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -60.49 158.92 11.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.066 -1.879 . . . . 72.13 113.681 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--O 1.252 1.203 1 N-CA-C 97.751 -4.907 . . . . 70.41 97.751 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.699 0 N-CA-C 106.533 -2.627 . . . . 73.45 106.533 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -148.71 137.07 21.14 Favored 'General case' 0 C--N 1.322 -0.603 1 N-CA-C 100.131 -4.026 . . . . 74.02 100.131 140.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.28 -158.49 31.14 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 120.529 1.513 . . . . 41.11 116.624 -173.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.3 p -104.7 -3.83 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 118.269 2.692 . . . . 71.24 118.269 -172.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.47 170.81 6.94 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 105.837 -1.912 . . . . 70.44 105.837 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -64.93 -167.92 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 N-CA-C 115.154 1.175 . . . . 60.11 115.154 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -47.24 133.18 12.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 116.75 2.13 . . . . 64.0 116.75 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.288 27.0 t0 -107.59 -169.34 1.51 Allowed 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 111.724 -2.489 . . . . 74.42 108.563 -173.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -62.17 -31.77 72.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 119.366 -2.084 . . . . 75.22 113.929 159.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -141.71 120.6 12.75 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 108.252 -1.018 . . . . 73.12 108.252 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.81 -133.54 32.01 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 119.126 -1.511 . . . . 61.22 114.668 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.2 151.04 25.95 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.84 0.856 . . . . 63.31 110.245 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -81.58 137.14 35.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 117.033 2.234 . . . . 73.55 117.033 -166.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -63.34 166.44 6.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 116.017 1.858 . . . . 74.41 116.017 -175.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--O 1.253 1.287 1 N-CA-C 99.241 -4.355 . . . . 72.33 99.241 164.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.157 1 N-CA-C 96.26 -6.736 . . . . 53.32 96.26 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -135.92 99.62 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 121.531 2.666 . . . . 41.02 113.339 167.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 178.02 47.36 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 109.106 -1.597 . . . . 65.4 109.106 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.85 106.74 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.669 1.235 . . . . 75.35 111.558 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.22 178.07 0.84 Allowed Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 102.884 -3.006 . . . . 62.3 102.884 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.61 -173.2 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 116.555 -1.83 . . . . 50.2 113.19 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -51.28 153.15 2.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 118.379 2.733 . . . . 73.23 118.379 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.251 38.0 t0 -155.69 166.96 31.92 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 126.996 2.118 . . . . 64.02 108.98 -170.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m -62.57 -22.8 66.63 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.333 1.605 . . . . 64.12 115.333 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -119.51 29.56 7.55 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.155 1.455 . . . . 70.13 109.765 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -89.57 0.52 Allowed Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.13 -0.941 . . . . 52.44 114.925 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.31 142.03 50.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.009 -1.108 . . . . 72.35 108.009 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.89 150.91 39.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 120.24 3.422 . . . . 74.31 120.24 -158.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -73.19 159.58 33.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.246 -1.343 . . . . 73.22 112.738 -171.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.6 t80 . . . . . 0 C--O 1.254 1.295 1 N-CA-C 99.272 -4.344 . . . . 61.53 99.272 161.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 N-CA-C 106.828 -2.509 . . . . 72.2 106.828 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -126.08 67.73 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.716 1.258 . . . . 73.33 113.314 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.16 -177.68 48.43 Favored Glycine 0 C--O 1.221 -0.703 0 C-N-CA 118.999 -1.572 . . . . 74.35 116.654 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 103.4 11.87 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.943 -0.739 . . . . 74.31 112.482 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.61 173.32 2.31 Favored Pre-proline 0 N--CA 1.47 0.567 0 N-CA-C 101.783 -3.414 . . . . 73.14 101.783 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 -163.0 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 117.712 -1.058 . . . . 72.22 113.189 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.35 142.26 5.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 118.829 2.9 . . . . 62.1 118.829 -168.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -142.07 168.96 18.51 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 111.357 -2.656 . . . . 71.41 107.345 -173.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -71.52 -13.32 61.76 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 119.812 -1.805 . . . . 74.03 112.257 172.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -122.8 38.99 4.05 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 123.625 1.679 . . . . 72.22 108.625 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.62 -79.19 1.16 Allowed Glycine 0 C--O 1.222 -0.613 0 CA-C-O 117.672 -1.627 . . . . 41.03 115.652 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.04 137.73 49.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.801 1.801 . . . . 74.14 110.35 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.88 148.94 26.01 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 120.051 3.352 . . . . 74.45 120.051 -161.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -77.77 -179.05 5.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.541 0.737 . . . . 73.12 109.98 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.255 1.359 1 N-CA-C 98.678 -4.564 . . . . 73.34 98.678 167.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.564 0 N-CA-C 107.294 -2.322 . . . . 73.41 107.294 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.462 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 56.9 m-85 -128.65 78.26 1.83 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.059 0.93 . . . . 73.53 110.122 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.04 178.85 44.28 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.651 -1.261 . . . . 73.4 114.506 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.77 108.21 18.61 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.325 -0.514 . . . . 64.32 109.707 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 174.57 1.71 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 100.553 -3.869 . . . . 73.23 100.553 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.04 -157.74 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 116.689 -1.741 . . . . 70.54 112.818 171.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.0 mt -50.53 145.06 6.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 118.605 2.817 . . . . 75.24 118.605 -167.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -138.38 171.35 14.51 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 128.391 2.677 . . . . 72.23 106.886 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m -66.39 -27.37 67.81 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 119.542 -1.974 . . . . 74.51 112.985 163.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -107.9 37.99 2.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.157 1.456 . . . . 62.53 108.841 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.3 -74.49 2.13 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-O 117.412 -1.771 . . . . 61.32 117.457 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -130.16 137.87 50.33 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.284 2.042 . . . . 71.33 109.816 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.02 153.19 21.47 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 119.88 3.289 . . . . 72.24 119.88 -159.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.462 ' HB3' ' H ' ' A' ' 2' ' ' PHE . 43.6 p90 -80.44 176.51 9.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.115 0.566 . . . . 74.24 110.773 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.2 t80 . . . . . 0 C--O 1.255 1.384 1 N-CA-C 98.454 -4.647 . . . . 64.53 98.454 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 N-CA-C 106.782 -2.527 . . . . 62.43 106.782 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -127.83 72.28 1.4 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.415 1.108 . . . . 73.53 112.578 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.93 -176.24 47.53 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.976 1.551 . . . . 72.1 116.976 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.49 96.47 8.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.974 -0.721 . . . . 75.1 112.69 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.98 172.39 4.6 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 102.266 -3.235 . . . . 64.54 102.266 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.0 -158.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.833 0.976 . . . . 75.0 112.554 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.9 mt -46.99 144.8 2.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 119.017 2.969 . . . . 72.5 119.017 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -151.33 165.73 33.15 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 111.284 -2.689 . . . . 74.25 107.202 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 m -64.75 -24.18 67.48 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 120.665 -1.272 . . . . 73.41 113.047 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -115.8 38.73 3.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 123.629 1.68 . . . . 74.15 109.065 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.4 -76.47 1.28 Allowed Glycine 0 C--O 1.226 -0.378 0 CA-C-O 117.837 -1.535 . . . . 55.32 116.524 174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.14 136.06 49.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.648 1.724 . . . . 71.42 110.561 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -84.68 151.43 24.45 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 120.706 3.595 . . . . 73.52 120.706 -160.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -82.57 -178.71 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.303 0.641 . . . . 75.21 110.06 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 t80 . . . . . 0 C--O 1.255 1.39 1 N-CA-C 98.725 -4.546 . . . . 74.45 98.725 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.104 1 N-CA-C 97.051 -6.42 . . . . 45.03 97.051 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -134.43 110.66 9.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 121.328 2.564 . . . . 72.54 111.109 165.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.56 -174.81 43.89 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.068 -0.813 . . . . 74.13 111.068 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 80.76 9.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.331 1.234 . . . . 74.05 114.331 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.97 171.04 7.97 Favored Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 105.655 -1.98 . . . . 74.42 105.655 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.61 -162.26 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.765 0 CA-C-N 119.759 0.95 . . . . 61.52 112.925 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -48.82 148.65 2.1 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 120.144 3.387 . . . . 63.45 120.144 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -155.11 167.59 29.85 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 111.785 -2.461 . . . . 71.42 108.418 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -64.76 -22.99 67.1 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.643 -1.286 . . . . 30.13 114.291 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -117.04 30.58 7.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.811 1.767 . . . . 53.03 109.071 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.59 -80.94 0.34 Allowed Glycine 0 C--O 1.225 -0.448 0 CA-C-O 118.394 -1.225 . . . . 73.21 116.083 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.62 130.75 47.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.087 1.443 . . . . 75.44 110.189 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.04 149.59 44.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 119.399 3.111 . . . . 71.31 119.399 -160.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -74.74 174.56 8.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.949 -1.023 . . . . 65.12 111.638 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.3 p90 . . . . . 0 C--O 1.253 1.283 1 N-CA-C 99.922 -4.103 . . . . 64.04 99.922 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 N-CA-C 108.777 -1.729 . . . . 74.31 108.777 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -161.74 154.02 19.71 Favored 'General case' 0 C--N 1.324 -0.512 1 N-CA-C 100.114 -4.032 . . . . 75.42 100.114 150.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.89 -158.33 27.65 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 120.905 1.684 . . . . 55.52 116.493 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 p -117.36 12.14 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.066 1.876 . . . . 72.12 116.066 -169.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.25 165.56 12.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 106.864 -1.532 . . . . 74.12 106.864 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.03 -176.56 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 119.384 0.816 . . . . 73.4 113.017 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.7 mt -51.96 134.15 32.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 118.275 2.694 . . . . 72.25 118.275 -147.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -99.63 174.47 6.22 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 111.985 -2.371 . . . . 63.0 105.696 171.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 t -65.8 -24.02 66.83 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.985 -1.697 . . . . 71.03 110.868 164.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -123.13 81.81 1.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.893 1.33 . . . . 72.43 109.622 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.17 -106.94 2.29 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.516 -0.85 . . . . 75.42 115.117 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.53 154.02 35.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.566 -0.901 . . . . 61.24 108.566 -173.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -96.07 152.34 18.63 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 117.475 2.398 . . . . 72.52 117.475 -166.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -69.72 179.3 2.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.497 -1.229 . . . . 73.03 113.349 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.4 p90 . . . . . 0 C--O 1.255 1.343 1 N-CA-C 98.94 -4.467 . . . . 73.21 98.94 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.132 1 N-CA-C 101.545 -4.622 . . . . 41.52 101.545 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.48 106.75 5.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.93 1.865 . . . . 72.22 111.367 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.89 172.33 43.92 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 107.497 -2.241 . . . . 63.52 107.497 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.95 113.25 20.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.512 1.156 . . . . 74.13 110.525 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -175.36 -179.64 0.39 Allowed Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 101.715 -3.439 . . . . 74.32 101.715 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.62 -170.69 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 117.03 -1.513 . . . . 73.15 112.601 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.46 145.19 11.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 116.292 1.96 . . . . 73.2 116.292 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.304 17.6 t0 -99.93 -163.17 1.01 Allowed 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 127.837 2.455 . . . . 73.43 108.22 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -67.02 -31.19 71.56 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.656 -2.528 . . . . 71.21 114.796 159.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -147.56 128.45 14.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.943 -2.614 . . . . 74.04 103.943 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.24 -150.57 37.26 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 119.627 -1.273 . . . . 30.01 112.732 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.1 mt -114.34 143.81 44.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.047 -1.094 . . . . 64.32 108.047 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -64.49 136.9 57.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.261 1.578 . . . . 73.3 115.261 -163.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -62.05 168.54 3.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.377 -1.283 . . . . 75.34 112.683 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 17.3 t80 . . . . . 0 C--O 1.253 1.269 1 N-CA-C 97.736 -4.913 . . . . 72.3 97.736 172.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.352 1 N-CA-C 97.131 -6.388 . . . . 75.33 97.131 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -131.05 105.76 7.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.625 2.213 . . . . 74.42 110.955 165.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.02 -176.2 45.83 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 108.658 -1.777 . . . . 75.44 108.658 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.42 105.06 17.55 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 115.295 1.591 . . . . 51.33 115.295 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.3 OUTLIER -177.54 175.4 0.56 Allowed Pre-proline 0 N--CA 1.478 0.968 0 N-CA-C 101.116 -3.661 . . . . 73.41 101.116 166.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.69 -164.16 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 CA-C-N 120.753 1.305 . . . . 71.14 114.902 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.4 mt -47.45 145.65 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 120.217 3.414 . . . . 72.22 120.217 -166.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -155.56 168.95 25.46 Favored 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 127.745 2.418 . . . . 74.12 107.958 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -58.56 -37.3 75.44 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.94 1.089 . . . . 71.42 113.94 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -106.12 30.3 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.265 1.507 . . . . 72.14 109.846 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.27 -77.84 0.23 Allowed Glycine 0 C--O 1.226 -0.386 0 CA-C-O 118.389 -1.228 . . . . 54.12 115.141 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.35 137.63 48.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.286 1.543 . . . . 73.22 112.361 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.4 130.86 43.69 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.56 2.059 . . . . 73.04 116.56 -166.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -79.51 170.24 16.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 54.32 111.65 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 46.8 t80 . . . . . 0 C--O 1.254 1.336 1 N-CA-C 99.14 -4.392 . . . . 73.34 99.14 165.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 0.065 1 N-CA-C 98.529 -5.828 . . . . 72.42 98.529 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -132.47 93.1 3.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.131 2.465 . . . . 74.51 112.526 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.74 -176.45 45.76 Favored Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.699 -1.76 . . . . 72.35 108.699 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.91 104.64 16.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 115.913 1.82 . . . . 73.1 115.913 -175.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -177.0 174.89 0.63 Allowed Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 100.828 -3.768 . . . . 71.41 100.828 166.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.82 -164.61 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 120.808 1.324 . . . . 73.31 115.461 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -47.21 144.66 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 119.669 3.211 . . . . 73.25 119.669 -167.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -156.54 166.11 34.34 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 127.484 2.314 . . . . 70.44 108.096 -169.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -28.26 67.85 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 116.398 1.999 . . . . 73.35 116.398 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -114.03 27.67 9.34 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 123.309 1.528 . . . . 62.44 109.202 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.49 -79.52 0.26 Allowed Glycine 0 C--O 1.226 -0.358 0 CA-C-O 118.499 -1.167 . . . . 73.5 115.193 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.51 136.4 47.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.119 1.459 . . . . 70.34 112.827 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.04 133.15 46.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.565 2.061 . . . . 62.31 116.565 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -88.18 170.59 10.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 63.35 111.071 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 C--O 1.256 1.426 1 N-CA-C 98.453 -4.647 . . . . 71.34 98.453 167.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.135 0 N-CA-C 103.719 -3.752 . . . . 60.11 103.719 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -138.06 110.39 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.002 1.401 . . . . 70.53 110.409 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.64 167.95 37.15 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 107.398 -2.281 . . . . 41.52 107.398 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.21 109.73 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.895 1.347 . . . . 74.32 109.954 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.81 178.27 0.61 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 102.439 -3.171 . . . . 72.22 102.439 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.2 -173.48 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 116.718 -1.722 . . . . 74.2 112.379 167.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.2 mt -50.72 139.28 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 115.849 1.796 . . . . 73.54 115.849 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.268 7.7 t0 -85.21 -164.77 1.05 Allowed 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 112.115 -2.311 . . . . 64.31 107.502 168.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -65.79 -33.33 75.61 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.801 -2.437 . . . . 71.24 113.413 160.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -153.68 129.14 9.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 103.899 -2.63 . . . . 75.41 103.899 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.29 -156.92 26.41 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.757 -0.735 . . . . 72.04 111.384 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.0 mt -118.63 142.08 47.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.095 -1.817 . . . . 72.14 106.095 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -61.94 135.07 57.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.966 1.469 . . . . 74.31 114.966 -162.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -62.99 172.23 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.241 -1.345 . . . . 73.52 113.607 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.3 t80 . . . . . 0 C--O 1.254 1.324 1 N-CA-C 98.521 -4.622 . . . . 71.53 98.521 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.152 1 N-CA-C 101.165 -4.774 . . . . 73.33 101.165 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -106.78 150.05 26.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 101.284 -3.599 . . . . 74.44 101.284 161.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.39 -161.19 27.06 Favored Glycine 0 C--O 1.222 -0.609 0 CA-C-N 119.55 1.068 . . . . 72.11 112.242 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 p -108.88 -6.98 15.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.679 1.362 . . . . 61.45 114.679 -170.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -133.5 163.07 53.75 Favored Pre-proline 0 C--O 1.218 -0.572 0 N-CA-C 105.805 -1.924 . . . . 73.32 105.805 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.66 172.13 15.84 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 115.83 -2.314 . . . . 73.11 113.892 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . 0.411 2.5 pp 68.45 111.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 121.224 3.787 . . . . 73.32 121.224 169.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -174.8 168.78 3.59 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 100.923 -3.732 . . . . 65.21 100.923 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -68.82 -25.76 64.83 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 121.274 1.852 . . . . 63.24 111.639 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -99.45 15.23 27.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 123.006 1.384 . . . . 63.42 109.432 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.39 -36.74 4.01 Favored Glycine 0 N--CA 1.454 -0.134 0 N-CA-C 119.688 2.635 . . . . 64.44 119.688 170.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.06 128.28 43.24 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 116.943 2.201 . . . . 64.51 116.943 -173.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -72.0 132.44 44.28 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.048 -1.033 . . . . 72.21 111.8 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -99.56 133.62 43.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 63.21 111.949 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.1 t80 . . . . . 0 C--O 1.263 1.775 1 N-CA-C 95.979 -5.563 . . . . 71.45 95.979 161.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.31 0 N-CA-C 106.38 -2.688 . . . . 42.23 106.38 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -127.47 137.2 52.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 102.922 -2.992 . . . . 74.4 102.922 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.46 -169.4 41.89 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 107.735 -2.146 . . . . 65.43 107.735 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.1 p -97.41 -7.96 30.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 115.266 1.58 . . . . 72.31 115.266 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -102.69 157.03 34.53 Favored Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 121.745 -0.597 . . . . 73.41 111.129 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.94 176.49 7.59 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 116.46 -1.893 . . . . 50.23 112.138 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pp 40.68 74.04 0.11 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 118.74 2.867 . . . . 74.23 118.74 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -70.16 -174.16 0.77 Allowed 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.528 -1.358 . . . . 75.25 108.411 151.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -59.98 -36.06 76.35 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.499 -2.001 . . . . 75.04 113.184 162.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.53 132.79 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 102.554 -3.128 . . . . 74.22 102.554 167.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.55 -153.53 21.71 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 119.076 0.853 . . . . 63.4 113.556 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.03 136.84 47.04 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.326 0.65 . . . . 71.3 110.326 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.9 123.95 23.81 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.113 -0.992 . . . . 74.23 112.991 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -62.69 158.62 18.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.453 -1.703 . . . . 75.2 112.99 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.6 t80 . . . . . 0 C--O 1.256 1.447 1 N-CA-C 99.548 -4.241 . . . . 65.15 99.548 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.372 0 N-CA-C 104.251 -3.54 . . . . 72.23 104.251 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -138.59 125.01 20.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.02 -2.215 . . . . 64.32 105.02 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.86 -162.52 30.25 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.913 -0.875 . . . . 63.01 110.913 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.9 p -100.72 -2.06 33.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.867 2.173 . . . . 72.21 116.867 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 163.04 20.3 Favored Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 121.335 -0.853 . . . . 74.35 109.599 -174.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.0 178.13 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 119.08 0.707 . . . . 63.12 112.598 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.6 mt -50.91 135.26 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 118.551 2.797 . . . . 52.32 118.551 -149.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.305 5.9 t0 -78.88 -164.11 0.56 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 110.88 -2.873 . . . . 64.02 108.467 171.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.7 p -65.78 -33.59 76.21 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 118.404 -2.685 . . . . 74.13 113.692 160.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -147.28 128.87 15.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.558 -2.386 . . . . 75.33 104.558 173.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.65 -159.31 44.14 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 119.889 1.222 . . . . 72.23 113.86 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.4 147.0 23.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.119 0.568 . . . . 74.24 109.549 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -72.02 128.78 36.79 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 115.266 1.58 . . . . 75.44 115.266 -169.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -62.48 158.64 17.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.0 -1.909 . . . . 61.12 114.499 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--O 1.253 1.25 1 N-CA-C 99.353 -4.314 . . . . 73.11 99.353 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.606 0 N-CA-C 105.143 -3.183 . . . . 71.12 105.143 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -147.08 118.71 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.742 -1.577 . . . . 75.54 106.742 150.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.19 -158.65 28.43 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.103 1.201 . . . . 43.42 116.103 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.4 p -91.38 2.96 56.03 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 119.494 3.146 . . . . 74.31 119.494 -169.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.52 170.16 6.37 Favored Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 121.073 -1.017 . . . . 72.22 108.299 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -64.31 -172.23 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 119.76 0.95 . . . . 61.31 113.895 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 mp -48.31 134.89 14.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 117.715 2.487 . . . . 73.31 117.715 -165.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.324 23.1 t0 -100.73 -165.75 1.24 Allowed 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 128.989 2.916 . . . . 62.41 109.142 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -31.01 70.32 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 119.204 -2.185 . . . . 61.04 115.364 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -147.91 127.11 12.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.796 -1.928 . . . . 65.33 105.796 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 -144.36 43.24 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 119.056 -1.545 . . . . 75.13 113.864 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.81 146.89 26.71 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.636 0.774 . . . . 73.43 110.433 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -73.62 134.85 43.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 116.369 1.988 . . . . 75.41 116.369 -168.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -60.49 158.92 11.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.066 -1.879 . . . . 72.13 113.681 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--O 1.252 1.203 1 N-CA-C 97.751 -4.907 . . . . 70.41 97.751 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.699 0 N-CA-C 106.533 -2.627 . . . . 73.45 106.533 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -148.71 137.07 21.14 Favored 'General case' 0 C--N 1.322 -0.603 1 N-CA-C 100.131 -4.026 . . . . 74.02 100.131 140.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.28 -158.49 31.14 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 120.529 1.513 . . . . 41.11 116.624 -173.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.3 p -104.7 -3.83 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 118.269 2.692 . . . . 71.24 118.269 -172.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.47 170.81 6.94 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 105.837 -1.912 . . . . 70.44 105.837 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -64.93 -167.92 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 N-CA-C 115.154 1.175 . . . . 60.11 115.154 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -47.24 133.18 12.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 116.75 2.13 . . . . 64.0 116.75 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.288 27.0 t0 -107.59 -169.34 1.51 Allowed 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 111.724 -2.489 . . . . 74.42 108.563 -173.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -62.17 -31.77 72.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 119.366 -2.084 . . . . 75.22 113.929 159.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -141.71 120.6 12.75 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 108.252 -1.018 . . . . 73.12 108.252 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.81 -133.54 32.01 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 119.126 -1.511 . . . . 61.22 114.668 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.2 151.04 25.95 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.84 0.856 . . . . 63.31 110.245 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -81.58 137.14 35.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 117.033 2.234 . . . . 73.55 117.033 -166.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -63.34 166.44 6.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 116.017 1.858 . . . . 74.41 116.017 -175.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--O 1.253 1.287 1 N-CA-C 99.241 -4.355 . . . . 72.33 99.241 164.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.157 1 N-CA-C 96.26 -6.736 . . . . 53.32 96.26 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -135.92 99.62 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 121.531 2.666 . . . . 41.02 113.339 167.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 178.02 47.36 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 109.106 -1.597 . . . . 65.4 109.106 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.85 106.74 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.669 1.235 . . . . 75.35 111.558 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.22 178.07 0.84 Allowed Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 102.884 -3.006 . . . . 62.3 102.884 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.61 -173.2 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 116.555 -1.83 . . . . 50.2 113.19 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -51.28 153.15 2.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 118.379 2.733 . . . . 73.23 118.379 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.251 38.0 t0 -155.69 166.96 31.92 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 126.996 2.118 . . . . 64.02 108.98 -170.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m -62.57 -22.8 66.63 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.333 1.605 . . . . 64.12 115.333 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -119.51 29.56 7.55 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.155 1.455 . . . . 70.13 109.765 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -89.57 0.52 Allowed Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.13 -0.941 . . . . 52.44 114.925 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.31 142.03 50.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.009 -1.108 . . . . 72.35 108.009 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.89 150.91 39.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 120.24 3.422 . . . . 74.31 120.24 -158.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -73.19 159.58 33.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.246 -1.343 . . . . 73.22 112.738 -171.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.6 t80 . . . . . 0 C--O 1.254 1.295 1 N-CA-C 99.272 -4.344 . . . . 61.53 99.272 161.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 N-CA-C 106.828 -2.509 . . . . 72.2 106.828 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -126.08 67.73 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.716 1.258 . . . . 73.33 113.314 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.16 -177.68 48.43 Favored Glycine 0 C--O 1.221 -0.703 0 C-N-CA 118.999 -1.572 . . . . 74.35 116.654 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 103.4 11.87 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.943 -0.739 . . . . 74.31 112.482 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.61 173.32 2.31 Favored Pre-proline 0 N--CA 1.47 0.567 0 N-CA-C 101.783 -3.414 . . . . 73.14 101.783 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 -163.0 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 117.712 -1.058 . . . . 72.22 113.189 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.35 142.26 5.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 118.829 2.9 . . . . 62.1 118.829 -168.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -142.07 168.96 18.51 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 111.357 -2.656 . . . . 71.41 107.345 -173.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -71.52 -13.32 61.76 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 119.812 -1.805 . . . . 74.03 112.257 172.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -122.8 38.99 4.05 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 123.625 1.679 . . . . 72.22 108.625 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.62 -79.19 1.16 Allowed Glycine 0 C--O 1.222 -0.613 0 CA-C-O 117.672 -1.627 . . . . 41.03 115.652 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.04 137.73 49.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.801 1.801 . . . . 74.14 110.35 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.88 148.94 26.01 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 120.051 3.352 . . . . 74.45 120.051 -161.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -77.77 -179.05 5.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.541 0.737 . . . . 73.12 109.98 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.255 1.359 1 N-CA-C 98.678 -4.564 . . . . 73.34 98.678 167.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.564 0 N-CA-C 107.294 -2.322 . . . . 73.41 107.294 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.462 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 56.9 m-85 -128.65 78.26 1.83 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.059 0.93 . . . . 73.53 110.122 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.04 178.85 44.28 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.651 -1.261 . . . . 73.4 114.506 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.77 108.21 18.61 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.325 -0.514 . . . . 64.32 109.707 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 174.57 1.71 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 100.553 -3.869 . . . . 73.23 100.553 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.04 -157.74 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 116.689 -1.741 . . . . 70.54 112.818 171.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.0 mt -50.53 145.06 6.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 118.605 2.817 . . . . 75.24 118.605 -167.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -138.38 171.35 14.51 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 128.391 2.677 . . . . 72.23 106.886 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m -66.39 -27.37 67.81 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 119.542 -1.974 . . . . 74.51 112.985 163.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -107.9 37.99 2.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.157 1.456 . . . . 62.53 108.841 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.3 -74.49 2.13 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-O 117.412 -1.771 . . . . 61.32 117.457 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -130.16 137.87 50.33 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.284 2.042 . . . . 71.33 109.816 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.02 153.19 21.47 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 119.88 3.289 . . . . 72.24 119.88 -159.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.462 ' HB3' ' H ' ' A' ' 2' ' ' PHE . 43.6 p90 -80.44 176.51 9.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.115 0.566 . . . . 74.24 110.773 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.2 t80 . . . . . 0 C--O 1.255 1.384 1 N-CA-C 98.454 -4.647 . . . . 64.53 98.454 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 N-CA-C 106.782 -2.527 . . . . 62.43 106.782 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -127.83 72.28 1.4 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.415 1.108 . . . . 73.53 112.578 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.93 -176.24 47.53 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.976 1.551 . . . . 72.1 116.976 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.49 96.47 8.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.974 -0.721 . . . . 75.1 112.69 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.98 172.39 4.6 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 102.266 -3.235 . . . . 64.54 102.266 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.0 -158.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.833 0.976 . . . . 75.0 112.554 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.9 mt -46.99 144.8 2.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 119.017 2.969 . . . . 72.5 119.017 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -151.33 165.73 33.15 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 111.284 -2.689 . . . . 74.25 107.202 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 m -64.75 -24.18 67.48 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 120.665 -1.272 . . . . 73.41 113.047 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -115.8 38.73 3.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 123.629 1.68 . . . . 74.15 109.065 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.4 -76.47 1.28 Allowed Glycine 0 C--O 1.226 -0.378 0 CA-C-O 117.837 -1.535 . . . . 55.32 116.524 174.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.14 136.06 49.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.648 1.724 . . . . 71.42 110.561 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -84.68 151.43 24.45 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 120.706 3.595 . . . . 73.52 120.706 -160.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -82.57 -178.71 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.303 0.641 . . . . 75.21 110.06 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 t80 . . . . . 0 C--O 1.255 1.39 1 N-CA-C 98.725 -4.546 . . . . 74.45 98.725 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.104 1 N-CA-C 97.051 -6.42 . . . . 45.030000000000001 97.051 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -134.43 110.66 9.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 121.328 2.564 . . . . 72.540000000000006 111.109 165.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.56 -174.81 43.89 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.068 -0.813 . . . . 74.129999999999995 111.068 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 80.76 9.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.331 1.234 . . . . 74.049999999999997 114.331 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.97 171.04 7.97 Favored Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 105.655 -1.98 . . . . 74.420000000000002 105.655 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.61 -162.26 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.765 0 CA-C-N 119.759 0.95 . . . . 61.520000000000003 112.925 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -48.82 148.65 2.1 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 120.144 3.387 . . . . 63.450000000000003 120.144 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -155.11 167.59 29.85 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 111.785 -2.461 . . . . 71.420000000000002 108.418 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -64.76 -22.99 67.1 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.643 -1.286 . . . . 30.129999999999999 114.291 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -117.04 30.58 7.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.811 1.767 . . . . 53.030000000000001 109.071 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.59 -80.94 0.34 Allowed Glycine 0 C--O 1.225 -0.448 0 CA-C-O 118.394 -1.225 . . . . 73.209999999999994 116.083 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.62 130.75 47.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.087 1.443 . . . . 75.439999999999998 110.189 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.04 149.59 44.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 119.399 3.111 . . . . 71.310000000000002 119.399 -160.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -74.74 174.56 8.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.949 -1.023 . . . . 65.120000000000005 111.638 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.3 p90 . . . . . 0 C--O 1.253 1.283 1 N-CA-C 99.922 -4.103 . . . . 64.040000000000006 99.922 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 N-CA-C 108.777 -1.729 . . . . 74.310000000000002 108.777 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -161.74 154.02 19.71 Favored 'General case' 0 C--N 1.324 -0.512 1 N-CA-C 100.114 -4.032 . . . . 75.420000000000002 100.114 150.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.89 -158.33 27.65 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 120.905 1.684 . . . . 55.520000000000003 116.493 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 p -117.36 12.14 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.066 1.876 . . . . 72.120000000000005 116.066 -169.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.25 165.56 12.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 106.864 -1.532 . . . . 74.120000000000005 106.864 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.03 -176.56 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 119.384 0.816 . . . . 73.400000000000006 113.017 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.7 mt -51.96 134.15 32.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 118.275 2.694 . . . . 72.25 118.275 -147.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -99.63 174.47 6.22 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 111.985 -2.371 . . . . 63.0 105.696 171.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 t -65.8 -24.02 66.83 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.985 -1.697 . . . . 71.030000000000001 110.868 164.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -123.13 81.81 1.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.893 1.33 . . . . 72.430000000000007 109.622 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.17 -106.94 2.29 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.516 -0.85 . . . . 75.420000000000002 115.117 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.53 154.02 35.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.566 -0.901 . . . . 61.240000000000002 108.566 -173.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -96.07 152.34 18.63 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 117.475 2.398 . . . . 72.519999999999996 117.475 -166.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -69.72 179.3 2.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.497 -1.229 . . . . 73.030000000000001 113.349 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.4 p90 . . . . . 0 C--O 1.255 1.343 1 N-CA-C 98.94 -4.467 . . . . 73.209999999999994 98.94 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.132 1 N-CA-C 101.545 -4.622 . . . . 41.520000000000003 101.545 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.48 106.75 5.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.93 1.865 . . . . 72.219999999999999 111.367 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.89 172.33 43.92 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 107.497 -2.241 . . . . 63.520000000000003 107.497 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.95 113.25 20.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.512 1.156 . . . . 74.129999999999995 110.525 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -175.36 -179.64 0.39 Allowed Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 101.715 -3.439 . . . . 74.319999999999993 101.715 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.62 -170.69 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 117.03 -1.513 . . . . 73.150000000000006 112.601 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.46 145.19 11.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 116.292 1.96 . . . . 73.200000000000003 116.292 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.304 17.6 t0 -99.93 -163.17 1.01 Allowed 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 127.837 2.455 . . . . 73.430000000000007 108.22 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -67.02 -31.19 71.56 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.656 -2.528 . . . . 71.209999999999994 114.796 159.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -147.56 128.45 14.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.943 -2.614 . . . . 74.040000000000006 103.943 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.24 -150.57 37.26 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 119.627 -1.273 . . . . 30.010000000000002 112.732 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.1 mt -114.34 143.81 44.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.047 -1.094 . . . . 64.319999999999993 108.047 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -64.49 136.9 57.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.261 1.578 . . . . 73.299999999999997 115.261 -163.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -62.05 168.54 3.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.377 -1.283 . . . . 75.340000000000003 112.683 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 17.3 t80 . . . . . 0 C--O 1.253 1.269 1 N-CA-C 97.736 -4.913 . . . . 72.299999999999997 97.736 172.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.352 1 N-CA-C 97.131 -6.388 . . . . 75.329999999999998 97.131 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -131.05 105.76 7.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.625 2.213 . . . . 74.420000000000002 110.955 165.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.02 -176.2 45.83 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 108.658 -1.777 . . . . 75.439999999999998 108.658 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.42 105.06 17.55 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 115.295 1.591 . . . . 51.329999999999998 115.295 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.3 OUTLIER -177.54 175.4 0.56 Allowed Pre-proline 0 N--CA 1.478 0.968 0 N-CA-C 101.116 -3.661 . . . . 73.409999999999997 101.116 166.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.69 -164.16 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 CA-C-N 120.753 1.305 . . . . 71.140000000000001 114.902 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.4 mt -47.45 145.65 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 120.217 3.414 . . . . 72.219999999999999 120.217 -166.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -155.56 168.95 25.46 Favored 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 127.745 2.418 . . . . 74.120000000000005 107.958 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -58.56 -37.3 75.44 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.94 1.089 . . . . 71.420000000000002 113.94 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -106.12 30.3 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.265 1.507 . . . . 72.140000000000001 109.846 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.27 -77.84 0.23 Allowed Glycine 0 C--O 1.226 -0.386 0 CA-C-O 118.389 -1.228 . . . . 54.119999999999997 115.141 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.35 137.63 48.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.286 1.543 . . . . 73.219999999999999 112.361 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.4 130.86 43.69 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.56 2.059 . . . . 73.040000000000006 116.56 -166.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -79.51 170.24 16.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 54.32 111.65 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.443 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 46.8 t80 . . . . . 0 C--O 1.254 1.336 1 N-CA-C 99.14 -4.392 . . . . 73.340000000000003 99.14 165.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 0.065 1 N-CA-C 98.529 -5.828 . . . . 72.420000000000002 98.529 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -132.47 93.1 3.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.131 2.465 . . . . 74.510000000000005 112.526 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.74 -176.45 45.76 Favored Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.699 -1.76 . . . . 72.349999999999994 108.699 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.91 104.64 16.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 115.913 1.82 . . . . 73.099999999999994 115.913 -175.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -177.0 174.89 0.63 Allowed Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 100.828 -3.768 . . . . 71.409999999999997 100.828 166.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.82 -164.61 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 120.808 1.324 . . . . 73.310000000000002 115.461 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -47.21 144.66 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 119.669 3.211 . . . . 73.25 119.669 -167.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -156.54 166.11 34.34 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 127.484 2.314 . . . . 70.439999999999998 108.096 -169.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -28.26 67.85 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 116.398 1.999 . . . . 73.349999999999994 116.398 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -114.03 27.67 9.34 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 123.309 1.528 . . . . 62.439999999999998 109.202 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.49 -79.52 0.26 Allowed Glycine 0 C--O 1.226 -0.358 0 CA-C-O 118.499 -1.167 . . . . 73.5 115.193 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.51 136.4 47.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.119 1.459 . . . . 70.340000000000003 112.827 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.04 133.15 46.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.565 2.061 . . . . 62.310000000000002 116.565 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -88.18 170.59 10.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 63.350000000000001 111.071 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 C--O 1.256 1.426 1 N-CA-C 98.453 -4.647 . . . . 71.340000000000003 98.453 167.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.135 0 N-CA-C 103.719 -3.752 . . . . 60.109999999999999 103.719 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -138.06 110.39 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.002 1.401 . . . . 70.530000000000001 110.409 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.64 167.95 37.15 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 107.398 -2.281 . . . . 41.520000000000003 107.398 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.21 109.73 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.895 1.347 . . . . 74.319999999999993 109.954 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.81 178.27 0.61 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 102.439 -3.171 . . . . 72.219999999999999 102.439 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.2 -173.48 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 116.718 -1.722 . . . . 74.200000000000003 112.379 167.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.2 mt -50.72 139.28 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 115.849 1.796 . . . . 73.540000000000006 115.849 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.268 7.7 t0 -85.21 -164.77 1.05 Allowed 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 112.115 -2.311 . . . . 64.310000000000002 107.502 168.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -65.79 -33.33 75.61 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.801 -2.437 . . . . 71.239999999999995 113.413 160.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -153.68 129.14 9.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 103.899 -2.63 . . . . 75.409999999999997 103.899 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.29 -156.92 26.41 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.757 -0.735 . . . . 72.040000000000006 111.384 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.0 mt -118.63 142.08 47.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.095 -1.817 . . . . 72.140000000000001 106.095 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -61.94 135.07 57.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.966 1.469 . . . . 74.310000000000002 114.966 -162.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -62.99 172.23 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.241 -1.345 . . . . 73.519999999999996 113.607 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.3 t80 . . . . . 0 C--O 1.254 1.324 1 N-CA-C 98.521 -4.622 . . . . 71.530000000000001 98.521 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.152 1 N-CA-C 101.165 -4.774 . . . . 73.329999999999998 101.165 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -106.78 150.05 26.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 101.284 -3.599 . . . . 74.439999999999998 101.284 161.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.39 -161.19 27.06 Favored Glycine 0 C--O 1.222 -0.609 0 CA-C-N 119.55 1.068 . . . . 72.109999999999999 112.242 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 p -108.88 -6.98 15.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.679 1.362 . . . . 61.450000000000003 114.679 -170.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -133.5 163.07 53.75 Favored Pre-proline 0 C--O 1.218 -0.572 0 N-CA-C 105.805 -1.924 . . . . 73.319999999999993 105.805 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.66 172.13 15.84 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 115.83 -2.314 . . . . 73.109999999999999 113.892 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . 0.411 2.5 pp 68.45 111.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 121.224 3.787 . . . . 73.319999999999993 121.224 169.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -174.8 168.78 3.59 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 100.923 -3.732 . . . . 65.209999999999994 100.923 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -68.82 -25.76 64.83 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 121.274 1.852 . . . . 63.240000000000002 111.639 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -99.45 15.23 27.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 123.006 1.384 . . . . 63.420000000000002 109.432 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.39 -36.74 4.01 Favored Glycine 0 N--CA 1.454 -0.134 0 N-CA-C 119.688 2.635 . . . . 64.439999999999998 119.688 170.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.06 128.28 43.24 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 116.943 2.201 . . . . 64.510000000000005 116.943 -173.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -72.0 132.44 44.28 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.048 -1.033 . . . . 72.209999999999994 111.8 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -99.56 133.62 43.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 63.210000000000001 111.949 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.1 t80 . . . . . 0 C--O 1.263 1.775 1 N-CA-C 95.979 -5.563 . . . . 71.450000000000003 95.979 161.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.31 0 N-CA-C 106.38 -2.688 . . . . 42.229999999999997 106.38 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -127.47 137.2 52.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 102.922 -2.992 . . . . 74.400000000000006 102.922 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.46 -169.4 41.89 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 107.735 -2.146 . . . . 65.430000000000007 107.735 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.1 p -97.41 -7.96 30.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 115.266 1.58 . . . . 72.310000000000002 115.266 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -102.69 157.03 34.53 Favored Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 121.745 -0.597 . . . . 73.409999999999997 111.129 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.94 176.49 7.59 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 116.46 -1.893 . . . . 50.229999999999997 112.138 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pp 40.68 74.04 0.11 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 118.74 2.867 . . . . 74.230000000000004 118.74 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -70.16 -174.16 0.77 Allowed 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.528 -1.358 . . . . 75.25 108.411 151.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -59.98 -36.06 76.35 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.499 -2.001 . . . . 75.040000000000006 113.184 162.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.53 132.79 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 102.554 -3.128 . . . . 74.219999999999999 102.554 167.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.55 -153.53 21.71 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 119.076 0.853 . . . . 63.399999999999999 113.556 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.03 136.84 47.04 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.326 0.65 . . . . 71.299999999999997 110.326 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.9 123.95 23.81 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.113 -0.992 . . . . 74.230000000000004 112.991 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -62.69 158.62 18.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.453 -1.703 . . . . 75.200000000000003 112.99 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.6 t80 . . . . . 0 C--O 1.256 1.447 1 N-CA-C 99.548 -4.241 . . . . 65.150000000000006 99.548 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.372 0 N-CA-C 104.251 -3.54 . . . . 72.230000000000004 104.251 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -138.59 125.01 20.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.02 -2.215 . . . . 64.319999999999993 105.02 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.86 -162.52 30.25 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.913 -0.875 . . . . 63.009999999999998 110.913 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.9 p -100.72 -2.06 33.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.867 2.173 . . . . 72.209999999999994 116.867 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 163.04 20.3 Favored Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 121.335 -0.853 . . . . 74.349999999999994 109.599 -174.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.0 178.13 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 119.08 0.707 . . . . 63.119999999999997 112.598 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.6 mt -50.91 135.26 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 118.551 2.797 . . . . 52.32 118.551 -149.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.305 5.9 t0 -78.88 -164.11 0.56 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 110.88 -2.873 . . . . 64.019999999999996 108.467 171.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.7 p -65.78 -33.59 76.21 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 118.404 -2.685 . . . . 74.129999999999995 113.692 160.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -147.28 128.87 15.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.558 -2.386 . . . . 75.329999999999998 104.558 173.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.65 -159.31 44.14 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 119.889 1.222 . . . . 72.230000000000004 113.86 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.4 147.0 23.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.119 0.568 . . . . 74.239999999999995 109.549 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -72.02 128.78 36.79 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 115.266 1.58 . . . . 75.439999999999998 115.266 -169.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -62.48 158.64 17.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.0 -1.909 . . . . 61.119999999999997 114.499 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--O 1.253 1.25 1 N-CA-C 99.353 -4.314 . . . . 73.109999999999999 99.353 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.606 0 N-CA-C 105.143 -3.183 . . . . 71.120000000000005 105.143 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -147.08 118.71 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.742 -1.577 . . . . 75.540000000000006 106.742 150.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.19 -158.65 28.43 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.103 1.201 . . . . 43.420000000000002 116.103 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.4 p -91.38 2.96 56.03 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 119.494 3.146 . . . . 74.310000000000002 119.494 -169.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.52 170.16 6.37 Favored Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 121.073 -1.017 . . . . 72.219999999999999 108.299 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -64.31 -172.23 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 119.76 0.95 . . . . 61.310000000000002 113.895 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 mp -48.31 134.89 14.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 117.715 2.487 . . . . 73.310000000000002 117.715 -165.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.324 23.1 t0 -100.73 -165.75 1.24 Allowed 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 128.989 2.916 . . . . 62.409999999999997 109.142 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -31.01 70.32 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 119.204 -2.185 . . . . 61.039999999999999 115.364 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -147.91 127.11 12.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.796 -1.928 . . . . 65.329999999999998 105.796 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 -144.36 43.24 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 119.056 -1.545 . . . . 75.129999999999995 113.864 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.81 146.89 26.71 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.636 0.774 . . . . 73.430000000000007 110.433 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -73.62 134.85 43.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 116.369 1.988 . . . . 75.409999999999997 116.369 -168.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -60.49 158.92 11.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.066 -1.879 . . . . 72.129999999999995 113.681 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--O 1.252 1.203 1 N-CA-C 97.751 -4.907 . . . . 70.409999999999997 97.751 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.699 0 N-CA-C 106.533 -2.627 . . . . 73.450000000000003 106.533 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -148.71 137.07 21.14 Favored 'General case' 0 C--N 1.322 -0.603 1 N-CA-C 100.131 -4.026 . . . . 74.019999999999996 100.131 140.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.28 -158.49 31.14 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 120.529 1.513 . . . . 41.109999999999999 116.624 -173.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.3 p -104.7 -3.83 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 118.269 2.692 . . . . 71.239999999999995 118.269 -172.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.47 170.81 6.94 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 105.837 -1.912 . . . . 70.439999999999998 105.837 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -64.93 -167.92 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 N-CA-C 115.154 1.175 . . . . 60.109999999999999 115.154 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -47.24 133.18 12.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 116.75 2.13 . . . . 64.0 116.75 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.288 27.0 t0 -107.59 -169.34 1.51 Allowed 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 111.724 -2.489 . . . . 74.420000000000002 108.563 -173.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -62.17 -31.77 72.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 119.366 -2.084 . . . . 75.219999999999999 113.929 159.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -141.71 120.6 12.75 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 108.252 -1.018 . . . . 73.120000000000005 108.252 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.81 -133.54 32.01 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 119.126 -1.511 . . . . 61.219999999999999 114.668 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.2 151.04 25.95 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.84 0.856 . . . . 63.310000000000002 110.245 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -81.58 137.14 35.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 117.033 2.234 . . . . 73.549999999999997 117.033 -166.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -63.34 166.44 6.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 116.017 1.858 . . . . 74.409999999999997 116.017 -175.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--O 1.253 1.287 1 N-CA-C 99.241 -4.355 . . . . 72.329999999999998 99.241 164.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.157 1 N-CA-C 96.26 -6.736 . . . . 53.32 96.26 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -135.92 99.62 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 121.531 2.666 . . . . 41.020000000000003 113.339 167.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 178.02 47.36 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 109.106 -1.597 . . . . 65.400000000000006 109.106 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.85 106.74 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.669 1.235 . . . . 75.349999999999994 111.558 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.22 178.07 0.84 Allowed Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 102.884 -3.006 . . . . 62.299999999999997 102.884 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.61 -173.2 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 116.555 -1.83 . . . . 50.200000000000003 113.19 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -51.28 153.15 2.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 118.379 2.733 . . . . 73.230000000000004 118.379 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.251 38.0 t0 -155.69 166.96 31.92 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 126.996 2.118 . . . . 64.019999999999996 108.98 -170.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m -62.57 -22.8 66.63 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.333 1.605 . . . . 64.120000000000005 115.333 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -119.51 29.56 7.55 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.155 1.455 . . . . 70.129999999999995 109.765 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -89.57 0.52 Allowed Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.13 -0.941 . . . . 52.439999999999998 114.925 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.31 142.03 50.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.009 -1.108 . . . . 72.349999999999994 108.009 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.89 150.91 39.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 120.24 3.422 . . . . 74.310000000000002 120.24 -158.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -73.19 159.58 33.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.246 -1.343 . . . . 73.219999999999999 112.738 -171.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.6 t80 . . . . . 0 C--O 1.254 1.295 1 N-CA-C 99.272 -4.344 . . . . 61.530000000000001 99.272 161.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 N-CA-C 106.828 -2.509 . . . . 72.200000000000003 106.828 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -126.08 67.73 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.716 1.258 . . . . 73.329999999999998 113.314 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.16 -177.68 48.43 Favored Glycine 0 C--O 1.221 -0.703 0 C-N-CA 118.999 -1.572 . . . . 74.349999999999994 116.654 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 103.4 11.87 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.943 -0.739 . . . . 74.310000000000002 112.482 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.61 173.32 2.31 Favored Pre-proline 0 N--CA 1.47 0.567 0 N-CA-C 101.783 -3.414 . . . . 73.140000000000001 101.783 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 -163.0 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 117.712 -1.058 . . . . 72.219999999999999 113.189 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.35 142.26 5.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 118.829 2.9 . . . . 62.100000000000001 118.829 -168.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -142.07 168.96 18.51 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 111.357 -2.656 . . . . 71.409999999999997 107.345 -173.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -71.52 -13.32 61.76 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 119.812 -1.805 . . . . 74.030000000000001 112.257 172.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -122.8 38.99 4.05 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 123.625 1.679 . . . . 72.219999999999999 108.625 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.62 -79.19 1.16 Allowed Glycine 0 C--O 1.222 -0.613 0 CA-C-O 117.672 -1.627 . . . . 41.030000000000001 115.652 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.04 137.73 49.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.801 1.801 . . . . 74.140000000000001 110.35 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.88 148.94 26.01 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 120.051 3.352 . . . . 74.450000000000003 120.051 -161.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -77.77 -179.05 5.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.541 0.737 . . . . 73.120000000000005 109.98 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.255 1.359 1 N-CA-C 98.678 -4.564 . . . . 73.340000000000003 98.678 167.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.564 0 N-CA-C 107.294 -2.322 . . . . 73.409999999999997 107.294 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.462 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 56.9 m-85 -128.65 78.26 1.83 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.059 0.93 . . . . 73.530000000000001 110.122 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.04 178.85 44.28 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.651 -1.261 . . . . 73.400000000000006 114.506 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.77 108.21 18.61 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.325 -0.514 . . . . 64.319999999999993 109.707 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 174.57 1.71 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 100.553 -3.869 . . . . 73.230000000000004 100.553 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.04 -157.74 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 116.689 -1.741 . . . . 70.540000000000006 112.818 171.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.0 mt -50.53 145.06 6.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 118.605 2.817 . . . . 75.239999999999995 118.605 -167.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -138.38 171.35 14.51 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 128.391 2.677 . . . . 72.230000000000004 106.886 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m -66.39 -27.37 67.81 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 119.542 -1.974 . . . . 74.510000000000005 112.985 163.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -107.9 37.99 2.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.157 1.456 . . . . 62.530000000000001 108.841 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.3 -74.49 2.13 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-O 117.412 -1.771 . . . . 61.32 117.457 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -130.16 137.87 50.33 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.284 2.042 . . . . 71.329999999999998 109.816 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.02 153.19 21.47 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 119.88 3.289 . . . . 72.239999999999995 119.88 -159.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.462 ' HB3' ' H ' ' A' ' 2' ' ' PHE . 43.6 p90 -80.44 176.51 9.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.115 0.566 . . . . 74.239999999999995 110.773 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.2 t80 . . . . . 0 C--O 1.255 1.384 1 N-CA-C 98.454 -4.647 . . . . 64.530000000000001 98.454 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 N-CA-C 106.782 -2.527 . . . . 62.43 106.782 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -127.83 72.28 1.4 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.415 1.108 . . . . 73.530000000000001 112.578 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.93 -176.24 47.53 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.976 1.551 . . . . 72.099999999999994 116.976 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.49 96.47 8.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.974 -0.721 . . . . 75.099999999999994 112.69 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.98 172.39 4.6 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 102.266 -3.235 . . . . 64.540000000000006 102.266 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.0 -158.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.833 0.976 . . . . 75.0 112.554 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.9 mt -46.99 144.8 2.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 119.017 2.969 . . . . 72.5 119.017 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -151.33 165.73 33.15 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 111.284 -2.689 . . . . 74.25 107.202 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 m -64.75 -24.18 67.48 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 120.665 -1.272 . . . . 73.409999999999997 113.047 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -115.8 38.73 3.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 123.629 1.68 . . . . 74.150000000000006 109.065 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.4 -76.47 1.28 Allowed Glycine 0 C--O 1.226 -0.378 0 CA-C-O 117.837 -1.535 . . . . 55.32 116.524 174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.14 136.06 49.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.648 1.724 . . . . 71.420000000000002 110.561 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -84.68 151.43 24.45 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 120.706 3.595 . . . . 73.519999999999996 120.706 -160.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -82.57 -178.71 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.303 0.641 . . . . 75.209999999999994 110.06 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 t80 . . . . . 0 C--O 1.255 1.39 1 N-CA-C 98.725 -4.546 . . . . 74.450000000000003 98.725 168.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.104 1 N-CA-C 97.051 -6.42 . . . . 45.030000000000001 97.051 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -134.43 110.66 9.56 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 121.328 2.564 . . . . 72.540000000000006 111.109 165.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.56 -174.81 43.89 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.068 -0.813 . . . . 74.129999999999995 111.068 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.95 80.76 9.05 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.331 1.234 . . . . 74.049999999999997 114.331 -176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.97 171.04 7.97 Favored Pre-proline 0 N--CA 1.474 0.764 0 N-CA-C 105.655 -1.98 . . . . 74.420000000000002 105.655 174.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.61 -162.26 0.09 OUTLIER 'Trans proline' 0 CA--C 1.539 0.765 0 CA-C-N 119.759 0.95 . . . . 61.520000000000003 112.925 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -48.82 148.65 2.1 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 120.144 3.387 . . . . 63.450000000000003 120.144 -166.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -155.11 167.59 29.85 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 111.785 -2.461 . . . . 71.420000000000002 108.418 -172.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 m -64.76 -22.99 67.1 Favored 'General case' 0 C--O 1.221 -0.446 0 O-C-N 120.643 -1.286 . . . . 30.129999999999999 114.291 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -117.04 30.58 7.24 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 123.811 1.767 . . . . 53.030000000000001 109.071 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.59 -80.94 0.34 Allowed Glycine 0 C--O 1.225 -0.448 0 CA-C-O 118.394 -1.225 . . . . 73.209999999999994 116.083 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.7 mt -128.62 130.75 47.71 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.087 1.443 . . . . 75.439999999999998 110.189 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.04 149.59 44.76 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 119.399 3.111 . . . . 71.310000000000002 119.399 -160.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -74.74 174.56 8.98 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.949 -1.023 . . . . 65.120000000000005 111.638 -172.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 35.3 p90 . . . . . 0 C--O 1.253 1.283 1 N-CA-C 99.922 -4.103 . . . . 64.040000000000006 99.922 173.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.72 0 N-CA-C 108.777 -1.729 . . . . 74.310000000000002 108.777 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -161.74 154.02 19.71 Favored 'General case' 0 C--N 1.324 -0.512 1 N-CA-C 100.114 -4.032 . . . . 75.420000000000002 100.114 150.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.89 -158.33 27.65 Favored Glycine 0 C--O 1.222 -0.6 0 CA-C-N 120.905 1.684 . . . . 55.520000000000003 116.493 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 p -117.36 12.14 14.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 116.066 1.876 . . . . 72.120000000000005 116.066 -169.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.25 165.56 12.5 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 106.864 -1.532 . . . . 74.120000000000005 106.864 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -66.03 -176.56 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 119.384 0.816 . . . . 73.400000000000006 113.017 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.7 mt -51.96 134.15 32.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 118.275 2.694 . . . . 72.25 118.275 -147.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -99.63 174.47 6.22 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 111.985 -2.371 . . . . 63.0 105.696 171.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 t -65.8 -24.02 66.83 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.985 -1.697 . . . . 71.030000000000001 110.868 164.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -123.13 81.81 1.92 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.893 1.33 . . . . 72.430000000000007 109.622 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.17 -106.94 2.29 Favored Glycine 0 C--O 1.224 -0.486 0 C-N-CA 120.516 -0.85 . . . . 75.420000000000002 115.117 174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -120.53 154.02 35.9 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.566 -0.901 . . . . 61.240000000000002 108.566 -173.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -96.07 152.34 18.63 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 117.475 2.398 . . . . 72.519999999999996 117.475 -166.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -69.72 179.3 2.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.497 -1.229 . . . . 73.030000000000001 113.349 -176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 18.4 p90 . . . . . 0 C--O 1.255 1.343 1 N-CA-C 98.94 -4.467 . . . . 73.209999999999994 98.94 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.132 1 N-CA-C 101.545 -4.622 . . . . 41.520000000000003 101.545 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.48 106.75 5.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 119.93 1.865 . . . . 72.219999999999999 111.367 164.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -179.89 172.33 43.92 Favored Glycine 0 C--O 1.225 -0.415 0 N-CA-C 107.497 -2.241 . . . . 63.520000000000003 107.497 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.95 113.25 20.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.512 1.156 . . . . 74.129999999999995 110.525 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.0 OUTLIER -175.36 -179.64 0.39 Allowed Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 101.715 -3.439 . . . . 74.319999999999993 101.715 179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -68.62 -170.69 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 117.03 -1.513 . . . . 73.150000000000006 112.601 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.5 mt -52.46 145.19 11.85 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 116.292 1.96 . . . . 73.200000000000003 116.292 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.304 17.6 t0 -99.93 -163.17 1.01 Allowed 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 127.837 2.455 . . . . 73.430000000000007 108.22 173.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 m -67.02 -31.19 71.56 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.656 -2.528 . . . . 71.209999999999994 114.796 159.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -147.56 128.45 14.43 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.943 -2.614 . . . . 74.040000000000006 103.943 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.24 -150.57 37.26 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 119.627 -1.273 . . . . 30.010000000000002 112.732 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.1 mt -114.34 143.81 44.29 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.047 -1.094 . . . . 64.319999999999993 108.047 -177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -64.49 136.9 57.53 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 115.261 1.578 . . . . 73.299999999999997 115.261 -163.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -62.05 168.54 3.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.377 -1.283 . . . . 75.340000000000003 112.683 -176.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 17.3 t80 . . . . . 0 C--O 1.253 1.269 1 N-CA-C 97.736 -4.913 . . . . 72.299999999999997 97.736 172.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.352 1 N-CA-C 97.131 -6.388 . . . . 75.329999999999998 97.131 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -131.05 105.76 7.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 120.625 2.213 . . . . 74.420000000000002 110.955 165.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.02 -176.2 45.83 Favored Glycine 0 C--O 1.223 -0.552 0 N-CA-C 108.658 -1.777 . . . . 75.439999999999998 108.658 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.42 105.06 17.55 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 115.295 1.591 . . . . 51.329999999999998 115.295 -175.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HZ1' ' HB2' ' A' ' 15' ' ' PHE . 0.3 OUTLIER -177.54 175.4 0.56 Allowed Pre-proline 0 N--CA 1.478 0.968 0 N-CA-C 101.116 -3.661 . . . . 73.409999999999997 101.116 166.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -68.69 -164.16 0.11 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 CA-C-N 120.753 1.305 . . . . 71.140000000000001 114.902 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.4 mt -47.45 145.65 2.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 120.217 3.414 . . . . 72.219999999999999 120.217 -166.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -155.56 168.95 25.46 Favored 'General case' 0 C--O 1.209 -1.061 0 C-N-CA 127.745 2.418 . . . . 74.120000000000005 107.958 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -58.56 -37.3 75.44 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.94 1.089 . . . . 71.420000000000002 113.94 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -106.12 30.3 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 123.265 1.507 . . . . 72.140000000000001 109.846 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.27 -77.84 0.23 Allowed Glycine 0 C--O 1.226 -0.386 0 CA-C-O 118.389 -1.228 . . . . 54.119999999999997 115.141 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.4 mt -131.35 137.63 48.83 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.286 1.543 . . . . 73.219999999999999 112.361 -172.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -69.4 130.86 43.69 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.56 2.059 . . . . 73.040000000000006 116.56 -166.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -79.51 170.24 16.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.685 -1.143 . . . . 54.32 111.65 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.443 ' HB2' ' HZ1' ' A' ' 5' ' ' LYS . 46.8 t80 . . . . . 0 C--O 1.254 1.336 1 N-CA-C 99.14 -4.392 . . . . 73.340000000000003 99.14 165.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 0.065 1 N-CA-C 98.529 -5.828 . . . . 72.420000000000002 98.529 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -132.47 93.1 3.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.131 2.465 . . . . 74.510000000000005 112.526 170.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -177.74 -176.45 45.76 Favored Glycine 0 C--O 1.225 -0.468 0 N-CA-C 108.699 -1.76 . . . . 72.349999999999994 108.699 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.91 104.64 16.8 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 115.913 1.82 . . . . 73.099999999999994 115.913 -175.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -177.0 174.89 0.63 Allowed Pre-proline 0 N--CA 1.478 0.961 0 N-CA-C 100.828 -3.768 . . . . 71.409999999999997 100.828 166.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.82 -164.61 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 CA-C-N 120.808 1.324 . . . . 73.310000000000002 115.461 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.5 mt -47.21 144.66 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 119.669 3.211 . . . . 73.25 119.669 -167.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -156.54 166.11 34.34 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 127.484 2.314 . . . . 70.439999999999998 108.096 -169.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -28.26 67.85 Favored 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 116.398 1.999 . . . . 73.349999999999994 116.398 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -114.03 27.67 9.34 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 123.309 1.528 . . . . 62.439999999999998 109.202 178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.49 -79.52 0.26 Allowed Glycine 0 C--O 1.226 -0.358 0 CA-C-O 118.499 -1.167 . . . . 73.5 115.193 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.51 136.4 47.86 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.119 1.459 . . . . 70.340000000000003 112.827 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -70.04 133.15 46.91 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 116.565 2.061 . . . . 62.310000000000002 116.565 -166.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -88.18 170.59 10.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.447 -0.797 . . . . 63.350000000000001 111.071 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 . . . . . 0 C--O 1.256 1.426 1 N-CA-C 98.453 -4.647 . . . . 71.340000000000003 98.453 167.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.135 0 N-CA-C 103.719 -3.752 . . . . 60.109999999999999 103.719 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -138.06 110.39 7.41 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.002 1.401 . . . . 70.530000000000001 110.409 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.64 167.95 37.15 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 107.398 -2.281 . . . . 41.520000000000003 107.398 175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.21 109.73 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 118.895 1.347 . . . . 74.319999999999993 109.954 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.81 178.27 0.61 Allowed Pre-proline 0 N--CA 1.471 0.6 0 N-CA-C 102.439 -3.171 . . . . 72.219999999999999 102.439 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -68.2 -173.48 0.53 Allowed 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 116.718 -1.722 . . . . 74.200000000000003 112.379 167.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.2 mt -50.72 139.28 16.81 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 115.849 1.796 . . . . 73.540000000000006 115.849 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.268 7.7 t0 -85.21 -164.77 1.05 Allowed 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 112.115 -2.311 . . . . 64.310000000000002 107.502 168.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.5 p -65.79 -33.33 75.61 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 118.801 -2.437 . . . . 71.239999999999995 113.413 160.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -153.68 129.14 9.89 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 103.899 -2.63 . . . . 75.409999999999997 103.899 171.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.29 -156.92 26.41 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.757 -0.735 . . . . 72.040000000000006 111.384 -173.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.0 mt -118.63 142.08 47.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.095 -1.817 . . . . 72.140000000000001 106.095 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -61.94 135.07 57.4 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 114.966 1.469 . . . . 74.310000000000002 114.966 -162.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -62.99 172.23 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.241 -1.345 . . . . 73.519999999999996 113.607 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.3 t80 . . . . . 0 C--O 1.254 1.324 1 N-CA-C 98.521 -4.622 . . . . 71.530000000000001 98.521 169.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.152 1 N-CA-C 101.165 -4.774 . . . . 73.329999999999998 101.165 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -106.78 150.05 26.72 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 101.284 -3.599 . . . . 74.439999999999998 101.284 161.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 179.39 -161.19 27.06 Favored Glycine 0 C--O 1.222 -0.609 0 CA-C-N 119.55 1.068 . . . . 72.109999999999999 112.242 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.2 p -108.88 -6.98 15.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 114.679 1.362 . . . . 61.450000000000003 114.679 -170.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -133.5 163.07 53.75 Favored Pre-proline 0 C--O 1.218 -0.572 0 N-CA-C 105.805 -1.924 . . . . 73.319999999999993 105.805 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.66 172.13 15.84 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 115.83 -2.314 . . . . 73.109999999999999 113.892 178.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . 0.411 2.5 pp 68.45 111.73 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 121.224 3.787 . . . . 73.319999999999993 121.224 169.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -174.8 168.78 3.59 Favored 'General case' 0 C--O 1.212 -0.881 0 N-CA-C 100.923 -3.732 . . . . 65.209999999999994 100.923 -176.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -68.82 -25.76 64.83 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 121.274 1.852 . . . . 63.240000000000002 111.639 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -99.45 15.23 27.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 123.006 1.384 . . . . 63.420000000000002 109.432 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.39 -36.74 4.01 Favored Glycine 0 N--CA 1.454 -0.134 0 N-CA-C 119.688 2.635 . . . . 64.439999999999998 119.688 170.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.06 128.28 43.24 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 116.943 2.201 . . . . 64.510000000000005 116.943 -173.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -72.0 132.44 44.28 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.048 -1.033 . . . . 72.209999999999994 111.8 176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -99.56 133.62 43.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.519 -0.764 . . . . 63.210000000000001 111.949 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 41.1 t80 . . . . . 0 C--O 1.263 1.775 1 N-CA-C 95.979 -5.563 . . . . 71.450000000000003 95.979 161.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.31 0 N-CA-C 106.38 -2.688 . . . . 42.229999999999997 106.38 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -127.47 137.2 52.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 102.922 -2.992 . . . . 74.400000000000006 102.922 163.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.46 -169.4 41.89 Favored Glycine 0 C--O 1.224 -0.475 0 N-CA-C 107.735 -2.146 . . . . 65.430000000000007 107.735 -174.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.1 p -97.41 -7.96 30.54 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 115.266 1.58 . . . . 72.310000000000002 115.266 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -102.69 157.03 34.53 Favored Pre-proline 0 N--CA 1.468 0.464 0 O-C-N 121.745 -0.597 . . . . 73.409999999999997 111.129 -173.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -70.94 176.49 7.59 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 116.46 -1.893 . . . . 50.229999999999997 112.138 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 pp 40.68 74.04 0.11 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 118.74 2.867 . . . . 74.230000000000004 118.74 173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -70.16 -174.16 0.77 Allowed 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.528 -1.358 . . . . 75.25 108.411 151.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -59.98 -36.06 76.35 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 119.499 -2.001 . . . . 75.040000000000006 113.184 162.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -155.53 132.79 10.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 102.554 -3.128 . . . . 74.219999999999999 102.554 167.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.55 -153.53 21.71 Favored Glycine 0 CA--C 1.52 0.361 0 CA-C-N 119.076 0.853 . . . . 63.399999999999999 113.556 -174.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.7 mt -108.03 136.84 47.04 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 123.326 0.65 . . . . 71.299999999999997 110.326 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -71.9 123.95 23.81 Favored 'General case' 0 C--O 1.241 0.653 0 O-C-N 121.113 -0.992 . . . . 74.230000000000004 112.991 -169.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -62.69 158.62 18.01 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.453 -1.703 . . . . 75.200000000000003 112.99 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 58.6 t80 . . . . . 0 C--O 1.256 1.447 1 N-CA-C 99.548 -4.241 . . . . 65.150000000000006 99.548 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.372 0 N-CA-C 104.251 -3.54 . . . . 72.230000000000004 104.251 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -138.59 125.01 20.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 105.02 -2.215 . . . . 64.319999999999993 105.02 160.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 177.86 -162.52 30.25 Favored Glycine 0 C--O 1.223 -0.535 0 N-CA-C 110.913 -0.875 . . . . 63.009999999999998 110.913 -174.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.9 p -100.72 -2.06 33.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.867 2.173 . . . . 72.209999999999994 116.867 -172.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.86 163.04 20.3 Favored Pre-proline 0 N--CA 1.471 0.602 0 O-C-N 121.335 -0.853 . . . . 74.349999999999994 109.599 -174.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.0 178.13 1.61 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 119.08 0.707 . . . . 63.119999999999997 112.598 175.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.6 mt -50.91 135.26 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 118.551 2.797 . . . . 52.32 118.551 -149.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.305 5.9 t0 -78.88 -164.11 0.56 Allowed 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 110.88 -2.873 . . . . 64.019999999999996 108.467 171.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.7 p -65.78 -33.59 76.21 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 118.404 -2.685 . . . . 74.129999999999995 113.692 160.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -147.28 128.87 15.08 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 104.558 -2.386 . . . . 75.329999999999998 104.558 173.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.65 -159.31 44.14 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 119.889 1.222 . . . . 72.230000000000004 113.86 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.8 mt -95.4 147.0 23.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 123.119 0.568 . . . . 74.239999999999995 109.549 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -72.02 128.78 36.79 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 115.266 1.58 . . . . 75.439999999999998 115.266 -169.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -62.48 158.64 17.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 113.0 -1.909 . . . . 61.119999999999997 114.499 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--O 1.253 1.25 1 N-CA-C 99.353 -4.314 . . . . 73.109999999999999 99.353 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.606 0 N-CA-C 105.143 -3.183 . . . . 71.120000000000005 105.143 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -147.08 118.71 7.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.742 -1.577 . . . . 75.540000000000006 106.742 150.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.19 -158.65 28.43 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.103 1.201 . . . . 43.420000000000002 116.103 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.4 p -91.38 2.96 56.03 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 119.494 3.146 . . . . 74.310000000000002 119.494 -169.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.52 170.16 6.37 Favored Pre-proline 0 N--CA 1.475 0.822 0 O-C-N 121.073 -1.017 . . . . 72.219999999999999 108.299 -177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -64.31 -172.23 0.18 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 CA-C-N 119.76 0.95 . . . . 61.310000000000002 113.895 174.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.0 mp -48.31 134.89 14.32 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 117.715 2.487 . . . . 73.310000000000002 117.715 -165.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.324 23.1 t0 -100.73 -165.75 1.24 Allowed 'General case' 0 C--O 1.21 -0.988 0 C-N-CA 128.989 2.916 . . . . 62.409999999999997 109.142 -176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.72 -31.01 70.32 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 119.204 -2.185 . . . . 61.039999999999999 115.364 158.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -147.91 127.11 12.94 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.796 -1.928 . . . . 65.329999999999998 105.796 174.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 -144.36 43.24 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 119.056 -1.545 . . . . 75.129999999999995 113.864 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.0 mt -100.81 146.89 26.71 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.636 0.774 . . . . 73.430000000000007 110.433 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -73.62 134.85 43.75 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 116.369 1.988 . . . . 75.409999999999997 116.369 -168.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -60.49 158.92 11.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 113.066 -1.879 . . . . 72.129999999999995 113.681 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--O 1.252 1.203 1 N-CA-C 97.751 -4.907 . . . . 70.409999999999997 97.751 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.699 0 N-CA-C 106.533 -2.627 . . . . 73.450000000000003 106.533 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -148.71 137.07 21.14 Favored 'General case' 0 C--N 1.322 -0.603 1 N-CA-C 100.131 -4.026 . . . . 74.019999999999996 100.131 140.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 164.28 -158.49 31.14 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 120.529 1.513 . . . . 41.109999999999999 116.624 -173.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.3 p -104.7 -3.83 23.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 118.269 2.692 . . . . 71.239999999999995 118.269 -172.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.47 170.81 6.94 Favored Pre-proline 0 N--CA 1.476 0.831 0 N-CA-C 105.837 -1.912 . . . . 70.439999999999998 105.837 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -64.93 -167.92 0.1 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 N-CA-C 115.154 1.175 . . . . 60.109999999999999 115.154 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -47.24 133.18 12.31 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 116.75 2.13 . . . . 64.0 116.75 -169.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.288 27.0 t0 -107.59 -169.34 1.51 Allowed 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 111.724 -2.489 . . . . 74.420000000000002 108.563 -173.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 m -62.17 -31.77 72.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 119.366 -2.084 . . . . 75.219999999999999 113.929 159.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -141.71 120.6 12.75 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 108.252 -1.018 . . . . 73.120000000000005 108.252 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.81 -133.54 32.01 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 119.126 -1.511 . . . . 61.219999999999999 114.668 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -107.2 151.04 25.95 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.84 0.856 . . . . 63.310000000000002 110.245 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -81.58 137.14 35.55 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 117.033 2.234 . . . . 73.549999999999997 117.033 -166.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -63.34 166.44 6.38 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 116.017 1.858 . . . . 74.409999999999997 116.017 -175.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--O 1.253 1.287 1 N-CA-C 99.241 -4.355 . . . . 72.329999999999998 99.241 164.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.157 1 N-CA-C 96.26 -6.736 . . . . 53.32 96.26 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -135.92 99.62 4.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 121.531 2.666 . . . . 41.020000000000003 113.339 167.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.22 178.02 47.36 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 109.106 -1.597 . . . . 65.400000000000006 109.106 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.85 106.74 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.669 1.235 . . . . 75.349999999999994 111.558 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.22 178.07 0.84 Allowed Pre-proline 0 N--CA 1.473 0.7 0 N-CA-C 102.884 -3.006 . . . . 62.299999999999997 102.884 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.61 -173.2 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 116.555 -1.83 . . . . 50.200000000000003 113.19 172.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -51.28 153.15 2.16 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 118.379 2.733 . . . . 73.230000000000004 118.379 -173.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . 0.251 38.0 t0 -155.69 166.96 31.92 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 126.996 2.118 . . . . 64.019999999999996 108.98 -170.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.7 m -62.57 -22.8 66.63 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.333 1.605 . . . . 64.120000000000005 115.333 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -119.51 29.56 7.55 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 123.155 1.455 . . . . 70.129999999999995 109.765 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -89.57 0.52 Allowed Glycine 0 C--O 1.227 -0.298 0 CA-C-N 115.13 -0.941 . . . . 52.439999999999998 114.925 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -131.31 142.03 50.04 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.009 -1.108 . . . . 72.349999999999994 108.009 -176.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.89 150.91 39.01 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 120.24 3.422 . . . . 74.310000000000002 120.24 -158.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -73.19 159.58 33.27 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.246 -1.343 . . . . 73.219999999999999 112.738 -171.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.6 t80 . . . . . 0 C--O 1.254 1.295 1 N-CA-C 99.272 -4.344 . . . . 61.530000000000001 99.272 161.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.722 0 N-CA-C 106.828 -2.509 . . . . 72.200000000000003 106.828 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -126.08 67.73 1.2 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 118.716 1.258 . . . . 73.329999999999998 113.314 -178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 178.16 -177.68 48.43 Favored Glycine 0 C--O 1.221 -0.703 0 C-N-CA 118.999 -1.572 . . . . 74.349999999999994 116.654 177.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 103.4 11.87 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.943 -0.739 . . . . 74.310000000000002 112.482 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.61 173.32 2.31 Favored Pre-proline 0 N--CA 1.47 0.567 0 N-CA-C 101.783 -3.414 . . . . 73.140000000000001 101.783 174.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -69.76 -163.0 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 117.712 -1.058 . . . . 72.219999999999999 113.189 172.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 92.2 mt -48.35 142.26 5.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 118.829 2.9 . . . . 62.100000000000001 118.829 -168.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -142.07 168.96 18.51 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 111.357 -2.656 . . . . 71.409999999999997 107.345 -173.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.8 t -71.52 -13.32 61.76 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 119.812 -1.805 . . . . 74.030000000000001 112.257 172.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -122.8 38.99 4.05 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 123.625 1.679 . . . . 72.219999999999999 108.625 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.62 -79.19 1.16 Allowed Glycine 0 C--O 1.222 -0.613 0 CA-C-O 117.672 -1.627 . . . . 41.030000000000001 115.652 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.9 mt -131.04 137.73 49.3 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 119.801 1.801 . . . . 74.140000000000001 110.35 -175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -84.88 148.94 26.01 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 120.051 3.352 . . . . 74.450000000000003 120.051 -161.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -77.77 -179.05 5.72 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.541 0.737 . . . . 73.120000000000005 109.98 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 68.6 t80 . . . . . 0 C--O 1.255 1.359 1 N-CA-C 98.678 -4.564 . . . . 73.340000000000003 98.678 167.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.564 0 N-CA-C 107.294 -2.322 . . . . 73.409999999999997 107.294 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.462 ' H ' ' HB3' ' A' ' 14' ' ' PHE . 56.9 m-85 -128.65 78.26 1.83 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.059 0.93 . . . . 73.530000000000001 110.122 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.04 178.85 44.28 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.651 -1.261 . . . . 73.400000000000006 114.506 174.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.77 108.21 18.61 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.325 -0.514 . . . . 64.319999999999993 109.707 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 174.57 1.71 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 100.553 -3.869 . . . . 73.230000000000004 100.553 177.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.04 -157.74 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 116.689 -1.741 . . . . 70.540000000000006 112.818 171.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.0 mt -50.53 145.06 6.99 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 118.605 2.817 . . . . 75.239999999999995 118.605 -167.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -138.38 171.35 14.51 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 128.391 2.677 . . . . 72.230000000000004 106.886 -178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.8 m -66.39 -27.37 67.81 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 119.542 -1.974 . . . . 74.510000000000005 112.985 163.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -107.9 37.99 2.3 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.157 1.456 . . . . 62.530000000000001 108.841 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.3 -74.49 2.13 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-O 117.412 -1.771 . . . . 61.32 117.457 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.0 mt -130.16 137.87 50.33 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.284 2.042 . . . . 71.329999999999998 109.816 -176.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -88.02 153.19 21.47 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 119.88 3.289 . . . . 72.239999999999995 119.88 -159.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.462 ' HB3' ' H ' ' A' ' 2' ' ' PHE . 43.6 p90 -80.44 176.51 9.71 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.115 0.566 . . . . 74.239999999999995 110.773 -177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 51.2 t80 . . . . . 0 C--O 1.255 1.384 1 N-CA-C 98.454 -4.647 . . . . 64.530000000000001 98.454 166.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.729 0 N-CA-C 106.782 -2.527 . . . . 62.43 106.782 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -127.83 72.28 1.4 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 118.415 1.108 . . . . 73.530000000000001 112.578 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.93 -176.24 47.53 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 116.976 1.551 . . . . 72.099999999999994 116.976 176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.49 96.47 8.03 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.974 -0.721 . . . . 75.099999999999994 112.69 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.98 172.39 4.6 Favored Pre-proline 0 N--CA 1.472 0.628 0 N-CA-C 102.266 -3.235 . . . . 64.540000000000006 102.266 173.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.0 -158.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.541 0.843 0 CA-C-N 119.833 0.976 . . . . 75.0 112.554 173.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.9 mt -46.99 144.8 2.33 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 119.017 2.969 . . . . 72.5 119.017 -168.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -151.33 165.73 33.15 Favored 'General case' 0 C--O 1.213 -0.854 0 CA-C-N 111.284 -2.689 . . . . 74.25 107.202 -170.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.2 m -64.75 -24.18 67.48 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 120.665 -1.272 . . . . 73.409999999999997 113.047 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -115.8 38.73 3.22 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 123.629 1.68 . . . . 74.150000000000006 109.065 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.4 -76.47 1.28 Allowed Glycine 0 C--O 1.226 -0.378 0 CA-C-O 117.837 -1.535 . . . . 55.32 116.524 174.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.0 mt -129.14 136.06 49.69 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.648 1.724 . . . . 71.420000000000002 110.561 -176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -84.68 151.43 24.45 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 120.706 3.595 . . . . 73.519999999999996 120.706 -160.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -82.57 -178.71 7.18 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 123.303 0.641 . . . . 75.209999999999994 110.06 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 55.2 t80 . . . . . 0 C--O 1.255 1.39 1 N-CA-C 98.725 -4.546 . . . . 74.450000000000003 98.725 168.423 . . . . . . . . 1 1 . 1 stop_ save_